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Eukaryotic  DNA is  coiled  around  octamers  of  core  histone  proteins (H2A, 
H2B,  H3,  and  H4), forming  nucleosomes- the  basic  unit  of  chromatin. Nucleosome 
organization is  coordinated in  part  by  chromatin-associated  protein  complexes that 
modulate  histone  post-translational  modifications (PTMs). NuA3,  a  conserved S. 
cerevisiae histone  acetyltransferase (HAT)  complex,  engages trimethylation  on 
lysine  4 of  histone  H3 (H3K4me3) through the plant  homeodomain (PHD) finger in 
the  Yng1  subunit. Subsequently,  NuA3  acetylates  H3K14 through the  HAT  domain 
of  Sas3, leading to transcription initiation  at  NuA3-regulated genes. In  addition to 
Yng1,  NuA3  contains  other potential  protein-protein interaction  domains including 
the proline-tryptophan-tryptophan-proline (PWWP)  domain protein,  Pdp3, and the 
extra-terminal (ET) domain protein, Taf14, which have undefined functions. 
Here  we  performed co-immunoprecipitation  combined  with  mass-
spectrometry, biochemical binding  assays,  and  genetic  analyses to  classify the 
NuA3 HAT  complex into two functionaly  distinct forms:  NuA3a  and  NuA3b.  While 
NuA3a  uses the  PHD finger  of  Yng1 to  bind  H3K4me3  at the  5’-ends  of  open 
reading frames (ORFs),  NuA3b  uses the PWWP domain  of the  unique  subunit, 
Pdp3, to bind H3K36me3 at gene bodies. We find that deletion of PDP3 decreases 
NuA3-regulated transcription  and results in  growth  defects  when  combined  with 
transcription  elongation  mutants,  suggesting  NuA3b  acts  as  a  positive  elongation 
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factor.  Therefore, we ascribe a new function to H3K36me3 in yeast- in addition to 
repressing intergenic transcription, H3K36me3 also positively regulates transcription 
elongation via HAT complex recruitment into ORFs. 
Additionaly,  we performed mass-spectrometry and biochemical binding 
assays to further  characterize  ET  domains  as  mediators  of  protein-protein 
interactions.  Specificaly, the ET  domain  of  Taf14  engages residues  105-125 of 
Yng1 and this interaction is critical for NuA3-directed HAT activity. Interestingly, the 
H.  sapiens ET  domain  proteins  AF9  and  BRD4  also  engage residues  105-125 of 
Yng1.  Therefore, this S.  cerevisiae Yng1  sequence  may  contain  a  conserved  ET 
domain recognition motif and provide a novel mechanism to inhibit pathological ET 
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Chapter 1: General Introduction 
 
 
1.1 Epigenetics and Chromatin 
Although each cel in the human body contains the same DNA, diferent cel 
types express unique gene signatures that can be passed on through cel division1. 
This phenomenon, termed epigenetics, is defined as “the study of heritable changes 
that  occur  without  a  change in the  DNA  sequence”2-4. Epigenetic  mechanisms  are 
propagated in  part through  DNA  methylation,  modification of histone proteins,  and 
non-coding  RNAs,  which  colectively modulate gene  expression2,3,5,6. Disruption  of 
these  mechanisms leads to  aberant  gene  expression paterns and  epigenetic 
diseases including cancer and mental retardation syndromes7,8. Because of the high 
prevalence  and  poor  prognosis  of  such  diseases, understanding epigenetic 
pathways at a molecular level is critical for therapeutic development. 
In  eukaryotic  cels, DNA is  condensed within the  nucleus in the form  of 
chromatin. Chromatin is  comprised  of repetitive segments  of  DNA,  histones,  and 
non-histone  proteins9,10. The  basic  unit  of  chromatin is the  nucleosome,  which 
contains approximately 146 base pairs of DNA coiled around octamers of conserved 
core  histone  proteins  H2A,  H2B,  H3,  and  H411,12 (Figure  1A). Nucleosomes  are 
assembled with linker histone  H1 into dynamic higher-order chromatin structures, 
which act as bariers to multiple celular processes including DNA replication, DNA 












Figure 1 Nucleosome organization regulates transcription. A.) The basic unit 
of chromatin is the nucleosome, which is comprised of ~146bp of DNA coiled 
around an octamer of conserved core histone proteins H2A, H2B, H3, and H4 
(PDB: 1AOI)12. Histone tails can be modified by a variety of chemical groups 
including acetylation and methylation21,22. B.) Nucleosomes are organized into 
compact heterochromatic regions, which are largely transcriptionaly silent, and 
loose euchromatic regions, where the majority of transcription occurs13,18. Figure 
adapted from Dr. Romeo Papazyan. 
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mechanism  of regulation for these  processes17. For  example, in euchromatic 
domains nucleosomes  are loosely spaced and DNA is  accessible to the celular 
machinery,  alowing for active gene transcription13,18 (Figure 1B). Conversely, in 
heterochromatic domains nucleosomes are tightly spaced and gene transcription is 
largely repressed13,18 (Figure 1B). Nucleosome  organization is maintained by 
chromatin remodelers,  histone  chaperones,  and  other protein complexes that 
enzymaticaly modify histones19,20. 
 
1.2 Histone Post-Translational Modifications 
Histones  are basic globular  proteins that contain flexible  NH2-terminal tails, 
which protrude away from the nucleosome core12 (Figure 1A). These tails are highly 
conserved across species and covalently modified by hundreds of diverse chemical 
groups including  methylation,  acetylation,  phosphorylation,  and  ubiquitination21,22 
(Figures 1A,  2A). Importantly, histone post-translational modifications (PTMs) exist 
in dynamic combinations that are  discretely  positioned in the  genome, and thus 
histone  PTMs provide a  mechanism for  epigenetic  plasticity21-23 (Figures 2A,  2B). 
Furthermore, enzymatic complexes add (“write”), remove (“erase”), and bind (“read”) 
histone PTMs in a context dependent manner, alowing their functional outputs to be 
tightly regulated13,17,19,21 (Figures 3A, 3B). 
Histone  PTMs function  by directly altering chromatin  structure and recruiting 
non-histone efector proteins21. For  example,  modifications that  neutralize  positive 
charge, such  as acetylation, or add  negative  charge,  such  as phosphorylation, 














































Figure 2 Histone PTMs exist in dynamic combinations that occupy discrete 
regions of the genome. A.) A subset of PTMs known to exist on histone H322. The 
“histone code” hypothesis predicts that combinatorial histone PTMs act as binding 
sites for efector proteins that transduce downstream celular activities13,17,19. 
Adapted from Xu, Du, and Lau22. B.) Histone PTMs have distinct localization 
paterns31-33,52,53,268. H3K4me3 is enriched at the 5’-ends of actively transcribed 
genes and is associated with transcription initiation31-33,52,53,268. H3K36me3 is 
enriched throughout the open reading frames of actively transcribed genes and is 


































Figure  3  Enzymatic  complexes  bind,  add,  and remove  histone  PTMs in  a 
context  dependent  manner to regulate  downstream  celular functions. A/B.) 
Histone  PTMs  are recognized  by  specific  histone-binding “reader”  modules found 
within efector proteins49. Efector proteins recruit enzymatic proteins such as HATs 
and HDACs to discrete regions of the genome5,17,19,21,49. HATs acetylate chromatin 
to facilitate  histone  eviction  and transcriptional  activation13,24,30,31,38-40.  HDACs 
deacetylate  chromatin to facilitate  nucleosome  condensation  and transcriptional 
silencing37.  
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negatively  charged DNA24-28. Additionaly, the “histone  code”  hypothesis  predicts 
that combinatorial histone PTMs act as binding, stabilization, and occlusion sites for 
efector proteins, which  can transduce downstream activity through associated 
enzymatic  complexes13,17,19 (Figures 3A,  3B). As  site-specific acetylation and 
methylation are “writen” and “read”, respectively, by histone acetyltransferase (HAT) 
complexes to regulate gene expression, these modifications wil be explained below 
in depth. 
1.2A Lysine Acetylation 
 Lysine acetylation is associated  with euchromatin and transcriptional 
activation13,18,24,29,30. It is globaly enriched  at the promoter regions and 5’-ends  of 
open reading frames (ORFs)31-33. In this  context, acetylation ablates electrostatic 
histone-DNA interactions and recruits efector  proteins that  contain acetyl-binding 
bromodomains. Through these  mechanisms,  acetylation opens  chromatin  so that 
genes remain accessible to the transcriptional  machinery25-27,30,34-36. Acetylation is 
tightly regulated  by the opposing  enzymatic activities of HATs and  histone 
deacetylases (HDACs)37,38 (Figures 3A, 3B). 
 Interestingly, the placement  of  acetylation  at  specific lysine residues  can 
achieve  diverse celular functions. Type  A  nuclear  HATs, such  as  Gcn5, acetylate 
nucleosomes at multiple positions, including lysine 14 of histone H3 (H3K14ac)38-42. 
Chromatin remodelers,  such  as  RSC, bind H3K14ac  and link acetylation to  gene 
expression43,44. Type  B  cytoplasmic HATs, such  as HAT1, acetylate H4K5  and 
H4K841,45,46. The  histone  chaperone, CAF1,  binds H4K5ac/H4K8ac  and links 
acetylation to histone deposition47,48. Site-specific acetylation is further implicated in 
! 7!
multiple celular processes including DNA repair, DNA replication, and chromosome 
condensation21. 
1.2B Lysine and Arginine Methylation 
 Unlike  acetylation, methylation does  not  afect  histone  charge. Therefore, 
methylation functions  primarily through the recruitment  of efector  proteins that 
contain  methyl-binding “reader” domains5,21,49. Methylation is regulated  by the 
opposing  enzymatic  activities  of  histone methyltransferases (HMTs)  and  histone 
demethylases (HDMs)50,51. Lysine and arginine methylation are associated with both 
gene activation and silencing, depending on the position and state (mono, di, tri) of 
methylation5,21,52. For  example, the yeast Trithorax  group HMT,  Set1, trimethylates 
H3K4 at the 5’-ends of actively transcribed genes31-33,52-54. HATs, such as NuA3, and 
chromatin remodelers,  such  as NURF,  bind H3K4me3 to promote transcription 
initiation5,55,56. Conversely, the  mammalian  Polycomb  group  HMT, EZH2, 
trimethylates H3K27 at the  5’-ends  of transcriptionaly  silent genes52,57. The  co-
repressor complex, PRC1, binds H3K27me3 to repress transcription initiation58. 
Interestingly,  H3K4me3  and  H3K27me3  can  be found together (on the  same  or 
nearby  nucleosomes) in “bivalent  domains” at the promoters and  enhancers  of 
developmentaly regulated  genes59. Here, these  modifications  may “poise”  such 
genes for rapid activation or repression in response to developmental cues59. 
Similar to acetylation, the placement of methylation at specific lysine residues 
alows for diverse celular functions. For example, the yeast HMT, Set2, methylates 
H3K36 throughout ORFs of  actively transcribed  genes60-62. Histone  chaperones, 
such as Asf1, chromatin remodelers, such as Isw1b, and HATs, such as NuA3, bind 
! 8!
H3K36me3 to coordinate transcription elongation (as shown in Chapters 2 and 3)63-
66. Interestingly,  depending  on  which  efector  protein is  bound,  H3K36me3 is 
associated with both positive and negative regulation of the elongation pathway63-66. 
Lysine methylation is also implicated in other celular processes such as DNA repair. 
For example, the yeast HMT, Set9, methylates H4K20 at DNA damage sites67. The 
cel-cycle  checkpoint  protein, Crb2, binds  H4K20me to  coordinate DNA repair67-69. 
Accordingly,  a diverse family of  methyl-binding  domains  have  evolved to “read” 
histone methylation (see below)49. 
 
1.3 Histone Methyl-Binding “Reader” Domains 
Histone  PTMs  are recognized by  a  variety  of  efector proteins that  contain 
histone-binding “reader” domains13,17,19,49,70,71. Importantly, “reader”  domains 
recognize  both the  chemical  modification  and surounding  histone  sequence, 
alowing efector  proteins to  distinguish  between  closely related  modifications49,71. 
Efector proteins often form chromatin-associated complexes, which propagate 
celular functions through enzymatic or alosteric activities71-73 (Figures 3A,  3B). Of 
note, these complexes can be composed of multiple efector proteins, with multiple 
histone-binding domains73,74. Therefore,  a  combinatorial “histone  code”  may fine-
tune complex localization and activity13,17,19,73,74. 
In general, methylation is bound by an aromatic amino acid “cage” that forms 
cation-π interactions  between the  methyl-ammonium  group  and  aromatic 
residues75,76. To  distinguish  between methylated  histone  modifications,  methyl-
binding  domains  vary  widely in  both  structure  and recognition  motif49,70. For 
! 9!
example,  as  methylation  state increases (me1,  me2,  me3),  hydrophobicity 
increases, and therefore each  methyl  state requires  a “reader” with matched 
hydrophobicity49. Additionaly, methyl-binding pockets have multiple sites of contact 
with the histone tail that determine specificity49,71. 
1.3A PHD Finger 
 
 The  plant  homeodomain (PHD) finger is  defined  structuraly  by a  Cys4-His-
Cys3 motif, three loops  stabilized  by two  Zn
2+ molecules,  and  a two-stranded 
antiparalel β-sheet77. PHD fingers  are found in  many  chromatin-associated 
complexes, including  HATs  and  HDACs, and therefore are associated  with  both 
gene  activation  and repression55,56,78-83. Examples  of  histone  methylation  marks 
engaged by PHD fingers include H3K4me2/3, H3K9me2/3, and unmodified histone 
H3, which bind with low micromolar afinities55,56,74,80-83.  
In  addition to  an  aromatic “cage”, PHD fingers  achieve  specificity through 
multiple contact points with the histone tail49. In general, the histone tail forms a third 
antiparalel β-sheet with the PHD finger and the spacing of histone residues is critical 
for recognition49,55,56,80-83. For example, the S. cerevisiae Yng1 PHD finger contains 
two binding pockets to target H3K4me355 (Figure 4A). The first (Y157, S164, M168, 
and  W180) acts  as  a “cage” to  engage the trimethyl modification through  cation-π 
interactions  and the  second (D172,  E179,  and  W180) interacts  with H3R2 through 
hydrogen  bonding55 (Figure 4A). The molecular spacing R-X1-K distinguishes 
H3K4me3 from  H3K9me355,80,81. Through this  mechanism,  Yng1 binds  H3K4me3 





















Figure  4  Histone  methyl-binding  domains interact  with  distinct  histone tail 
residues to achieve specificity. A.) NMR structure of the S. cerevisiae Yng1 PHD 
finger bound to H3K4me3 peptide (PDB: 2JMI)55. An aromatic “cage” (Y157, S164, 
M168, and W180) engages the trimethyl residue through cation-π interactions55. A 
second  groove (D172,  E179,  and  W180) interacts  with  H3R2 through  hydrogen 
bonding55. B.) Crystal structure of the H. sapiens BRPF1 PWWP domain bound to 
H3K36me3  peptide (PDB:  2X4W)92.  The  aromatic “cage” (Y1096,  Y1099  and 
F1147)  engages the trimethyl residue through cation-π interactions92.  Hydrogen 
bonding  and  hydrophobic interactions  with  H3G33,  H3G34,  H3V35,  and  H3K36 
further promote specificity92.  
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1.3B PWWP Domain 
 
The proline-tryptophan-tryptophan-proline (PWWP)  domain belongs to the 
Tudor “royal” family70,84-86. PWWP  domains are structuraly defined  by a five-
stranded β-barel core,  an insertion  motif  between the  second  and third β-strands, 
and a variable C-terminal α-helix bundle86,87. Like PHD fingers, PWWP domains are 
found in  many  chromatin-associated  complexes73,74,86-89.  They are  associated  with 
diverse celular functions including  DNA  methylation  maintenance,  DNA repair, 
transcriptional regulation, HIV infection, and  alternative  splicing88,90-93. To  date, 
PWWP domains are known to bind H3K36me3, H3K79me3, and H4K20me1/3 with 
Kd’s ranging from  56µM to low milimolar afinities
66,86,91-103. In  certain  cases, 
afinities  are  greatly increased for  nucleosomal  substrates,  suggesting  PWWP 
domains synergisticaly bind methylated histones and DNA87,100,102. 
PWWP  domains  achieve histone-binding specificity in  part from  an aromatic 
“cage”  characteristic  of the  Tudor “royal” family70,86. Furthermore, like  PHD fingers, 
PWWP domains form multiple contact points with the histone tail86,92. For example, 
the H.  sapiens BRPF1 PWWP  domain  contains three binding pockets to target 
H3K36me392 (Figure  4B). The first (Y1096, Y1099 and F1147) acts as a “cage” to 
engage the trimethyl residue through cation-π interactions, the second (R1152 and 
W1154) interacts with H3G33, H3G34, and H3K36 through hydrogen bonding, and 
the third (V1127,  L1130,  and  W1156) forms  a hydrophobic  groove  surounding 
H3V3592 (Figure 4B). Of  note, the  placement  of  G33  and G34 relative to K36 is 
unique to  histone  H3,  and  contributes greatly to BRPF1 targeting92. Through this 
mechanism,  BRPF1 binds H3K36me3 with  a relatively  poor Kd of  2.7mM
92. 
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Interestingly, the  human ZYMND11 PWWP  domain requires histone variant H3.3 
(yeast  histone  H3) to  bind lysine  36 trimethylation103. Histone H3.3 contains the 
unique residue,  S31,  and therefore the  placement  of  S31 relative to  K36 also 
contributes to  PWWP  domain targeting103. Accordingly, BRPF1 may  bind 
H3.3K36me3 with a lower dissociation constant. 
 
1.4 NuA3 Histone Acetyltransferase Complex 
The S.  cerevisiae NuA3 complex  was identified in  1998,  as  a 450kDa 
nucleosomal  histone  H3 acetyltransferase104. NuA3 is  conserved in  humans  and 
“reads”  and “writes”  distinct  histone  PTMs to  coordinate transcriptional 
activation55,66,104-108. Therefore, NuA3 represents a model to study the “histone code” 
hypothesis in the context of gene expression. 
NuA3 stimulates transcription from  nucleosome-assembled template in  vitro 
and is required for the transcription  of  a  subset  of  genes in  vivo55,109. The  catalytic 
subunit  of  NuA3 is the  HAT, Sas3105. To  date, five other  complex  members  have 
been identified: Taf14, Yng1, Nto1, Eaf6, and Pdp355,66,105,106. 
1.4A Sas3 
 
Sas3 (ortholog of human MYST3) is essential for NuA3 complex integrity and 
specificaly acetylates  H3K1455,105,110. Sas3 is  bound  by the  histone  chaperone, 
FACT, and  H3K14ac is bound by the  chromatin-remodeler, RSC43,44,105. Together, 
these  co-activators facilitate NuA3-directed transcription44. SAS3 is syntheticaly 
lethal  with the  HAT, GCN5,  suggesting  NuA3  has  overlapping functions  with  other 
yeast HAT complexes such as ADA and SAGA110. 
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1.4B Yng1  
 
 Yng1 (ortholog  of  human ING5) is not  essential for NuA3 complex 
integrity106,111. However, Yng1 and the H3K4me3 HMT, Set1, are required for NuA3 
localization and HAT activity in vivo106-108. Specificaly, the PHD finger of Yng1 binds 
H3K4me3 at the promoter regions and 5’ends of actively transcribed genes, alowing 
Sas3 to acetylate H3K1455,107 (Figure 5A). Mutation of the Yng1 PHD finger results 
in genome-wide mislocalization of NuA3 from promoter regions to ORFs, decreases 
H3K14ac  at  NuA3-target genes,  and decreases the transcription  of these genes55. 
Interestingly, the interaction between NuA3  and  chromatin  also  depends on the N-
terminus  of  Yng1  and the H3K36me3  HMT,  Set2, indicating  additional histone 
contacts contribute to NuA3 localization66,108,112. 
Yng1 expression decreases exogenous human p53-driven transcript levels in 
a yeast reporter assay113. Although in  general NuA3 facilitates transcriptional 
activation, a subset of NuA3 proteins occupy heterochromatic bariers and contribute 
to  barier  maintenance114,115. Therefore,  NuA3 may  have undefined gene-specific 
silencing functions113-115. 
1.4C Pdp3 
A  non-stable  NuA3-associated  protein,  Pdp3 (Ylr455w),  was  previously 
detected using isotopic diferentiation of interactions as random or targeted (I-DIRT) 
mass-spectrometry55,116. Pdp3 contains a PWWP domain homologous to BRPF1, a 
member of the conserved H. sapiens MOZ/MORF HAT complex66,92,111 (Figure 5B). 
































Figure  5  The  NuA3  HAT  complex initiates transcription  and is  conserved in 
humans. A.) Model of the S. cerevisiae NuA3 HAT complex55,66. The PHD finger of 
Yng1  binds  H3K4me355,107,108.  The  HAT  domain  of  Sas3 then  acetylates  H3K14, 
leading to transcription initiation at a subset of genes55,104-106. B.) Model of the H. 
sapiens  MOZ/MORF  HAT  complex111.  BRPF1  contains  an  H3K36me3-binding 
PWWP domain that is absent in Nto1111. The BRPF1 PWWP domain is required for 







PHD fingers,  double  bromodomains)  are  split  between  Pdp3 (PWWP  domain)  and 
Nto1 (double  PHD fingers,  double  bromodomains)111,117.  Additionaly,  Pdp3  co-
localizes with Sas3 at heterochromatic bariers115. Together, these findings suggest 
that  Pdp3 is  a  novel  member  of the  NuA3  HAT  complex. In Chapters 2 and 3, I 
detail our work characterizing the function of Pdp3 within NuA3. 
 1.4D Taf14  
 
  Taf14 (ortholog  of  human  AF9  and  ENL) is a  YEATS (Yaf9,  ENL,  AF9, 
Taf14, Sas5) domain protein associated  with many celular processes including 
transcription initiation, transcription  elongation, cel cycle  progression,  cytoskeletal-
organization,  post-replication repair,  and  chromosome  stability61,105,118-132. Deletion 
of TAF14 is  not lethal,  but results in sensitivity to  UV light, γ-iradiation,  and 
genotoxic  agents. Deletion  of TAF14 also  causes growth  defects, cytoskeletal 
abnormalities, and decreased human p53 activation120,128,133-136. Although Taf14 has 
an important role in  diverse cellular processes, its  mechanism of  action remains 
poorly  understood137,138. Interestingly, AF9 binds  H3K9ac through  a  conserved 
YEATS  domain  and recruits the H3K79me3 HMT,  Dot1, to  active  chromatin139. 
Therefore, Taf14  may  similarly  bind acetylated  histones  and function as  a  scafold 
for transcriptional regulators. 
Taf14 is a  member  of  multiple chromatin-associated complexes, including 
transcription factors  TFID  and  TFIF,  chromatin-remodelers Ino80,  SWI/SNF, and 
RSC, and transcriptional co-activators NuA3 and Mediator104,105,120,122,129,131,140-143. In 
general,  Taf14 interacts  with the  catalytic  subunit  of  each complex through its  C-
terminus and  assists in catalytic activity through undefined mechanisms129,132. The 
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C-terminus  of  Taf14  contains  a  conserved  hydrophobic  cluster known  as an extra-
terminal (ET)  domain (also refered to  as the  Taf14 C-box)128,144. ET  domains  are 
predicted to generaly function as protein-protein interaction modules144. In Chapter 
4, I  detail  our  work  characterizing the  ET  domain  of  Taf14  within the NuA3 HAT 
complex and expand these findings to H. sapiens ET domain proteins144. 
 
1.5 NuA3 Human Homologs in Disease 
 The  human  homolog  of  NuA3 is the  MOZ/MORF HAT  complex110,111. 
MOZ/MORF is composed of the HAT MYST3 (ortholog of Sas3) and the scafolding 
subunits BRPF1 (ortholog of Nto1 and Pdp3), ING5 (ortholog of Yng1), and hEAF6 
(ortholog of Eaf6)145,146 (Figure  5B). MYST3, BRPF1, and ING5 contain conserved 
histone-binding “reader” domains that direct  MOZ/MORF HAT activity88,89,92,147,148. 
For  example, the PWWP  domain  of BRPF1 targets MOZ/MORF to H3K36me3-
enriched HOX genes, which control hematopoietic stem cel development92,149,150. 
 Chromosomal translocations and point mutations within MOZ/MORF result in 
epigenetic  diseases8,111,151-154. For  example, MOZ fuses to the HAT, p300/CBP, or 
the transcriptional  co-activator, TIF-2, resulting in aberant acetylation and 
overexpression  of HOX  genes151,155-159. Overexpression  of  HOX genes leads to 
hematopoietic stem cel transformation and leukemogenesis8,160. Importantly, MOZ-
associated leukemia,  such  as  acute  myeloid leukemia (AML), has a  very  poor 
prognosis161. Over 50,000  people  a  year  die from a lack  of  efective blood  cancer 
treatments8,161. As MOZ fusions assemble into the MOZ HAT complex, inhibition of 
“reader”  domains,  such  as the  BRPF1  PWWP  domain, may  provide  a treatment 
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mechanism for leukemia8,88,92,158. Additionaly, nul  mutations  of the tumor 
suppressor  gene ING5 are  associated  with  squamous  cel  carcinoma152-154. 
Therefore, further mechanistic insight into MOZ/MORF localization and HAT activity 
may uncover novel drug targets. 
 
1.6 Taf14 Human Homologs in Disease 
Human YEATS domain proteins AF9 and ENL (orthologs of Taf14) represent 
the two  most  common translocation  partners  of the MLL oncogene162,163. MLL-AF9 
and MLL-ENL translocations aberantly recruit  elongation factors to  HOX genes, 
resulting in HOX gene overexpression, hematopoietic stem cel transformation, and 
leukemogenesis160,164-170. Interestingly, MLL fusion  products include only the C-
terminus, and  not the  YEATS  domain, of AF9  and  ENL138. These  C-termini each 
contain a  conserved  ET  domain144. The  ET  domains  of  AF9  and ENL bind to 
transcriptional regulators including AF4, Dot1L, BCoR, hPC3, and Rnf2 to propagate 
pathogenesis166,171-177 (Figures  6A,  6B). As MLL translocations  account for 
approximately 3% of AML and 10% of acute lymphoid leukemia (ALL), ET domains 
may represent a promising pharmacological target178-180. 
Similarly, the C-terminus of human BRD4 contains  an  ET  domain that is 
conserved  with  Taf14144. The  BRD4  ET  domain binds transcriptional regulators 
including JMJD6, which activates the P-TEFb complex and releases paused RNAPI 
at  coding regions via long-range enhancer interactions181-184 (Figure  6B). Aberant 
RNAPI pause-release through BRD4 results in midline-carcinoma  and 






















Figure  6  Human  ET  domains  mediate  protein-protein interactions. A.)  NMR 
structure  of the H.  sapiens AF9  ET  domain  bound to  AF4 (PDB:  2LMO)176.  B.) 
Regulatory proteins (blue) known to interact with the H. sapiens AF9 or BRD4 ET 
domains (red)169,171-176,183,184.  ET  domains  are  predicted to  generaly function  as 




etc.)  have  striking  anti-cancer  efects, the BRD4  ET  domain remains 
pharmacologicaly uncharacterized186-194. 
 
1.7 Targeting Epigenetic Complexes for Therapeutic 
Development 
 
Precise localization of  chromatin-associated  complexes is  essential for 
transcriptional  control  and normal development195. The  deregulation  of  chromatin-
associated  complexes results in  many pathological conditions including  cancer, 
heart  disease, inflammation, and  neurological disease195-198. Therefore,  smal 
molecule inhibitors of chromatin-modifying enzymes have therapeutic potential195,199. 
For example, the pan HDAC inhibitor, valproic acid, is used as a mood stabilizer and 
anticonvulsant,  while the  Class I/I  HDAC inhibitor, Varinostat (SAHA), is used to 
treat advanced  cutaneous  T-cel lymphoma200. Valproic  acid  and  Varinostat  are 
curently in clinical trials for multiple cancer subtypes and neurological disorders200. 
Additionaly, epigenetic imaging agents have diagnostic potential.  For example, the 
Class I HDAC probe, Martinostat, is approved to quantitate HDAC  complex 
distribution in humans201. 
Compounds targeting acetyl-lysine “reader”  domains also have therapeutic 
potential202. For  example, the bromodomain  and  extra-terminal (BET) family 
bromodomain inhibitors, JQ1 and I-BET, selectively target BRD4 with Kd’s less than 
100nM188,189. JQ1 treatment of midline carcinoma mouse xenograft models leads to 
celular diferentiation and  apoptosis188,191,202,203. I-BET treatment of septic  shock 
mouse models downregulates the expression of inflammatory genes189,202. JQ1 and 
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I-BET also show preclinical promise for treating multiple forms  of leukemia, 
inflammation, and heart disease190,191,195,204,205. Curently, JQ1 and I-BET derivatives 
are in clinical trials for midline carcinoma, hematological cancer, and solid tumors187. 
In general, targeting “reader” domains of chromatin-associated complexes, as 
opposed to enzymatic  subunits, may simultaneously increase the eficacy and 
decrease the toxicity of epigenetic drug treatments202. Therefore, understanding the 
basic molecular mechanisms of protein-protein interaction domains within chromatin-

















Chapter 2: Pdp3 is a Member of the NuA3 HAT 
Complex that Specificaly Interacts with 
H3K36me3 through a Conserved PWWP 
Domain 
 
This research  was  originaly  published in  Molecular  and  Celular 
Proteomics. Tonya  M.  Gilbert,  Stephen  L.  McDaniel,  Stephanie  D. 
Byrum,  Jessica  A.  Cades,  Blair  C.  R.  Dancy,  Herschel  Wade,  Alan  J. 
Tacket,  Brian  D.  Strahl,  and  Sean  D.  Taverna. A  PWWP  Domain-
Containing  Protein  Targets the  NuA3  Acetyltransferase  Complex  via 
Histone  H3  Lysine  36 Trimethylation to  Coordinate  Transcriptional 
Elongation at Coding Regions. Molecular and Celular Proteomics. 2014; 





Chromatin  acts  as  a  barier to the transcriptional  machinery,  and  precise 
coordination of chromatin structure is required for the passage of RNA polymerase I 
(RNAPI)20,206,207. Chromatin structure is regulated by chromatin remodelers, histone 
chaperones,  and protein complexes that modulate  histone post-translational 
modifications (PTMs)19,20,49,208.  Together, these factors  ensure that DNA remains 
accessible to the transcriptional machinery and facilitate gene expression208. These 
factors also restore chromatin structure folowing the passage of RNAPI to prevent 
aberant transcription20,209. 
Histone PTMs occupy discrete genomic positions, such as promoter regions 
versus open reading frames (ORFs), and are  associated  with  distinct functional 
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states,  such  as active versus silent transcription17,19,31,33,53,210-212 (Figure  2B).  For 
example, histone H3 is often modified by trimethylation on lysine 4 (H3K4me3) and 
acetylation on lysine 14 (H3K14ac) at the 5’-ends of actively transcribed genes23,31-
33,52. In S.  cerevisiae,  H3K4me3 is  added by the  histone  methyltransferase (HMT), 
Set154. NuA3,  a  conserved  histone  acetyltransferase (HAT)  complex,  specificaly 
binds  H3K4me3 through the  plant  homeodomain (PHD) finger in the  Yng1 
subunit55,104-108,110,111 (Figure 5A). NuA3 then acetylates H3K14 on the same histone 
tail through the HAT domain of Sas355,105,106 (Figure  5A). Subsequently, regulatory 
complexes bind  either NuA3  subunits directly  or NuA3-catalyzed H3K14ac. For 
example, the  histone  chaperone,  FACT,  binds  Sas3 through  Spt16  and the 
chromatin-remodeler, RSC,  binds H3K14ac through  a tandem  bromodomain in 
Rsc443,44,105,213-215. RSC  also interacts with  NuA3 via Taf14129,216. Through  such 
interactions, NuA3 promotes transcription initiation at a subset of genes44,55.  
Other  histone  PTMs are positioned  within the ORFs of  actively transcribed 
genes20,209,211,217. In S. cerevisiae H3K36 methylation is added by the HMT, Set260. 
Set2 localizes to ORFs by  physicaly  binding the  hyperphosphorylated  C-terminal 
domain (CTD)  of  RNAPI and deposits H3K36me3 within  gene  bodies33,60,61,218-221. 
Accordingly, H3K36me3 is corelated specificaly with the regulation of transcription 
elongation61,62,218,219,222. H3K36me3 facilitates transcriptional fidelity by recruiting 
complexes that  colectively restore  chromatin  structure20,209,217. For  example, the 
histone deacetylase (HDAC) complex, Rpd3S, engages H3K36me2/3 to generate a 
hypoacetylated  environment  behind elongating  RNAPI223-229. Through this 
mechanism,  Rpd3S compacts  chromatin  and represses intergenic transcription223-
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229. H3K36me3 also  maintains  chromatin structure by  blocking trans-histone 
exchange20,63,64,65. For example, H3K36me3 precludes the histone chaperone, Asf1, 
from  depositing  newly  synthesized  histones  and recruits the ATP-dependent 
remodeler, Isw1b, to preserve  H3K36me3/hypoacetylated  histones63-65,230. In 
addition to transcriptional functions,  H3K36me3 is  also associated  with DNA 
methylation, dosage compensation, and alternative splicing217. 
It was previously determined that mutation of the Yng1 PHD finger results in 
the mislocalization  of  NuA3 from promoter regions to  ORFs55.  As  H3K36me3 is 
enriched in  ORFs,  we speculated that  NuA3 can  engage this  modification. 
H3K36me3 is recognized by proline-tryptophan-tryptophan-proline (PWWP) domain-
containing proteins, such as the Ioc4 subunit of Isw1b20,63,64. As Pdp3 (Ylr455w), an 
uncharacterized  PWWP  domain-containing  protein,  co-purifies  with  NuA3 subunits, 
we  hypothesized that Pdp3 is  a member of NuA3 that interacts with 
H3K36me355,70,115,231. 
Here, using mass  spectrometric, biochemical,  and  biophysical analyses,  we 
characterize  Pdp3  as a  novel  subunit of the NuA3 HAT complex. Pdp3 specificaly 
binds H3K36me3 in  vitro and in  vivo through  a  conserved PWWP  domain. 
Colectively,  our  data  suggest that while H3K36me3 generaly acts as  a repressive 
mark to  protect chromatin integrity  during transcription  elongation, in  yeast 






2.2A S. cerevisiae Strains 
Al strains used in Chapter 2 are described in Table 1. 
2.2B E. coli Plasmids 
Al constructs used in Chapter 2 are described in Table 2. 
2.2C Peptide Sequences 
 Al peptides used in Chapter 2 are listed in Table 3. 
2.2D Mass  Spectrometric  Protein Identification for  Celular  Pul 
Down Assays 
 
Pdp3-TAP  protein  complex  purification  was  performed  with S. cerevisiae grown to 
log  phase in  YPD, as  previously described to  maintain  complex integrity115,116. 
Proteins  co-purifying  with  Pdp3  were  subjected to tandem  MS  analysis of  peptides 
with  a  Thermo  LTQ-XL  mass  spectrometer  coupled to  an  Eksigent  nanoLC  2D 
system as previously described44. Tandem mass spectra were extracted by Thermo 
ExtractMSn  version  1.0.0.8 and analyzed by Mascot (Matrix  Science,  London,  UK; 
version 2.3.01). Scafold (version Scafold_4.0.1, Proteome Software Inc., Portland, 
OR) was used to validate MS/MS-based peptide and protein identifications. Al MS 
experiments and analyses were performed by the Alan J. Tacket laboratory at the 
University of Arkansas for Medical Sciences. I would like to acknowledge Drs. Alan 







S. cerevisiae strains used in Chapter 2 
Strain Genotype Source 
W303 
MATa; ura3-1; trp1Δ 2; leu2-3,112; his3-11,15; 
ade2-1; can1-100 
A. Tacket Lab 
YNG1-TAP 
























MATa leu2Δ0 met15Δ0 ura3Δ0 set2Δ:natMX 
YNG1-TAP:HIS3 
S. McDaniel, B. 
Strahl Lab 
YNG1-TAP; set1∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 set1Δ:hph YNG1-
TAP:HIS3 
S. McDaniel, B. 
Strahl Lab 
YNG1-TAP; pdp3∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 pdp3Δ:hph 
YNG1-TAP:HIS3 
S. McDaniel, B. 
Strahl Lab 
PDP3-TAP; set2∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 set2Δ:KanMX 
PDP3-TAP:HIS3 
S. McDaniel, B. 
Strahl Lab 
PDP3-TAP; set1∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 set1Δ:Hygro 
PDP3-TAP:HIS3 
S. McDaniel, B. 
Strahl Lab 
PDP3-TAP; yng1∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 yng1Δ:Hygro 
PDP3-TAP:HIS3 





E. coli plasmids used in Chapter 2 
Source: T. Gilbert, S. Taverna Lab  
Name Description Vector 
PDP3 FL Pdp3 aa 1-304 pET28 HisMBPFLAG 
PWWP(1-74) Pdp3 aa 1-74 pET28 HisMBPFLAG 
PWWP(1-110) Pdp3 aa 1-110 pET28 HisMBPFLAG 
PWWP(2-150) Pdp3 aa 2-150 pET28 HisMBPFLAG 
PWWP(1-219) Pdp3 aa 1-219 pET28 HisMBPFLAG 
C-term(74-304) Pdp3 aa 74-304 pET28 HisMBPFLAG 
PDP3 F18A FL Pdp3 aa 1-304 pET28 HisMBPFLAG 
PDP3 W21A FL Pdp3 aa 1-304 pET28 HisMBPFLAG 
PDP3 F48A FL Pdp3 aa 1-304 pET28 HisMBPFLAG 
PDP3 FL Pdp3 aa 1-304 pET32a 
PDP3 F18A FL Pdp3 aa 1-304 pET32a 





Peptides used in Chapter 2 
Sources: 5-FAM labeled peptides- Dr. B. Dancy, S. Taverna Lab; 
Biotin labeled peptides- C.D. Alis Lab and B. Strahl Lab 
Tag Name Sequence 
5-FAM  H3(1-15)K4me3 H2N-ARTK(me3)QTARKSTGGKA(KFluorescein)-NH2 
5-FAM  H3(29-43)K36me0 H2N-APSTGGVKKPHRYKP(KFluorescein)-NH2 
5-FAM  H3(29-43)K36me1 H2N-APSTGGVK(me)KPHRYKP(KFluorescein)-NH2 
5-FAM  H3(29-43)K36me2 H2N-APSTGGVK(me2)KPHRYKP(KFluorescein)-NH2 
5-FAM  H3(29-43)K36me3 H2N-APSTGGVK(me3)KPHRYKP(KFluorescein)-NH2 
5-FAM  H3(70-88)K79me3 H2N-LVREIAQDFK(me3)TDLRFQSSA(KFluorescein)-NH2 
5-FAM  H4(11-29)K20me3 H2N-GKGGAKRHRK(me3)ILRDNIQGI(KFluorescein)-NH2 
Biotin H3(1-20)Kme0 H2N-ARTKQTARKSTGGKAPRKQL(KBiot)-NH2 
Biotin H3(1-20)K4me3 H2N-ARTK(me3)QTARKSTGGKAPRKQL(KBiot)-NH2 
Biotin H3(1-20)K9me3  H2N-ARTKQTARK(me3)STGGKAPRKQL(KBiot)-NH2 
Biotin H3(19-35)K27me3 H2N-QLATKAARK(me3)SAPATGGV(KBiot)-NH2 
Biotin H3(15-43)Kme0 Ac-APRKQLATKAARKSAPSTGGVKKPHRYGG(KBiot)-NH2 
Biotin H3(15-43)K36me3 Ac-APRKQLATKAARKSAPSTGGVK(me3)KPHRYGG(KBiot)-NH2 
Biotin H4(11-27)Kme0 Ac-GKGGAKRHRKVLRDNIQ(Peg-Biot) 
Biotin H4(12-27)K20me3 H2N-KGGAKRHR K(me3)VLRDNIQ(KBiot)-NH2 
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2.2E Protein Expression 
PDP3 constructs  were  made  with  an  N-terminal  HIS6X-pfuMBP(60-434)-FLAG tag 
(pET28a  derivative  vector  obtained from the  Greg Bowman  Laboratory,  Johns 
Hopkins University) and/or an N-terminal Thioredoxin-HIS6X-S•tag tag (pET32a 
vector,  Milipore).  Proteins  were  exogenously  expressed in  chemicaly  competent 
BL21 E. coli (Invitrogen) after overnight induction with 1 mM IPTG at 18-20 ºC in LB 
medium. Point mutants were made with the QuikChange Site-Directed Mutagenesis 
Kit (Stratagene) and expressed as described.  
2.2F Protein Purification 
For  pul down  assays,  BL21  cels (pET28a  constructs)  were resuspended in 
purification  bufer (50  mM  Tris  pH  7.5,  500  mM  NaCl,  40  mM imidazole,  10% 
glycerol,  2  mM β-ME,  1  mM  PMSF,  2  mM  benzamidine,  pH  8.0)  and lysed  by 
sonication (Branson). Clarified lysate  was  nutated  with  Ni-NTA  agarose resin 
(Invitrogen) for at least 1 hr at 4 °C. Resin was washed with purification bufer and 
protein was eluted with purification bufer containing 300 mM imidazole. Protein was 
frozen in liquid nitrogen and stored at −80 °C. For fluorescence polarization assays, 
BL21 cels (pET32a constructs) were resuspended in purification bufer (50 mM Tris 
pH 7.7, 500 mM NaCl, 10% glycerol, 5 mM DTT, 1 mM PMSF, 2 mM benzamidine) 
and lysed  with  a  microfluidizer (Wats  Fluidair).  Clarified lysate  was run through  a 
BioScale Mini Profinity IMAC cartridge (BioRad) using an AKTA purifier system (GE 
Healthcare).  The  cartridge  was  washed  with  purification  bufer  containing  12  mM 
imidazole  and  protein  was  eluted  with  purification  bufer  containing  125  mM 
imidazole. Protein was exchanged into gel filtration bufer (50 mM Tris pH 7.5, 500 
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mM  NaCl,  10%  glycerol,  5  mM  DTT)  and  separated  by  a  Superdex  200  26/60 
column (GE Healthcare) using an AKTA purifier system (GE Healthcare). Monomeric 
protein  was frozen in liquid  nitrogen  and  stored  at −80 °C. I  would like to 
acknowledge the laboratories of  Drs.  Herschel  Wade and  Daniel  J.  Leahy for their 
technical assistance and critical guidance. 
2.2G Celular Pul Down Assays 
TAP-tagged S. cerevisiae strains were grown to mid-log phase in YPD, cryogenicaly 
lysed  with  a  mixer  mil (Retsch  MM301),  and  stored  at −80 °C. Cels (1  g  per  pul 
down condition) were homogenized (ProScientific) in 650 mM extraction bufer (650 
mM  NaCl,  20  mM  HEPES  pH  7.9,  25%  glycerol,  1.5  mM  MgCl2,  0.2  mM EDTA,  1 
mM PMSF, 0.2% Triton X-100, 1% BSA, 40 mM imidazole) at a ratio of 1 mL bufer 
per 1 g yeast and nutated for 1 hr at 4 °C. Clarified extracts were diluted to 300 mM 
NaCl  with ‘no-salt’  extraction  bufer,  mixed  with 100  µL per  sample  of Ni-NTA 
agarose resin (Invitrogen) pre-coated with Pdp3 protein, and nutated for 30 min at 4 
°C.  Resin  was  washed  5 times  with  300  mM  wash  bufer (300  mM  KCl,  20  mM 
HEPES  pH  7.9,  0.2%  Triton  X-100,  1%  BSA,  40  mM imidazole)  and  1 time  with 
bufer containing 10 mM NaCl and 4 mM HEPES pH 7.9. Resin was incubated in 2X 
SDS-PAGE loading  bufer  containing 300  mM imidazole for  10  min to  elute  Pdp3-
bound proteins. Samples were boiled for 5 min, resolved on 8% SDS-polyacrylamide 
gels, transfered to  PVDF  membrane,  and  probed  with  antibodies recognizing the 
PrA (DAKO  P0450,  1/1500)  and  FLAG (SIGMA  F3165,  1/1000) tags. Immunoblots 
were visualized using HRP-conjugated secondary antibody (NA931-1ML, 1/10,000) 
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and  ECL  solution (GE  Healthcare). Inputs represent  ~0.02-0.05%  of total  yeast 
lysate. 
2.2H Peptides Used for Pul Down Assays 
Peptides used for  pul  down  assays were obtained from the  C.  D.  Alis  Laboratory 
(The  Rockefeler  University)  and the University  of  North  Carolina  at  Chapel  Hil 
Peptide Synthesis and Araying Core Facility233. 
2.2I Peptide Pul Down Assays 
Steptavidin-coupled Dynabeads (Invitrogen) (25 µL per sample) were incubated with 
biotinylated histone peptides (1 µg per sample) in binding bufer (20 mM HEPES pH 
7.9, 150 mM NaCl, 0.5 mM PMSF, 20% glycerol, 0.2% Triton X-100, 1% BSA) for 1 
hr at room temperature. Unbound peptide was washed in binding bufer and beads 
were incubated  with  purified  Pdp3  proteins (20  µg  per  sample) for  1  hr  at room 
temperature. Beads  were  washed  3 times for  5  minutes  each  with  binding  bufer, 
and 1 time with bufer containing 4 mM HEPES pH 7.9, 10 mM NaCl, 0.5 mM PMSF, 
20% glycerol, and 0.2% Triton X-100. Peptide-bound proteins were eluted in boiling 
2X SDS-PAGE loading bufer. Samples were resolved on 15% SDS-polyacrylamide 
gels, transfered to  PVDF  membrane,  and  probed  with antibodies recognizing the 
FLAG (SIGMA F3165, 1/1000) and streptavidin (Molecular Probes S-911, 1/10,000) 
tags. Immunoblots  were  visualized  using HRP-conjugated  secondary  antibody 
(NA931-1ML, 1/10,000) and ECL solution (GE Healthcare). Inputs represent 0.5 µg 




2.2J Peptide Synthesis for Fluorescence Polarization Assays 
Fluorescent  peptides  were  synthesized  using  standard  Fmoc-solid  phase  peptide 
chemistry on a Prelude Peptide Synthesizer (Protein Technologies). Peptides were 
made on a 0.05 mMol scale with 4 equivalents of amino acids using Rink Amide AM 
resin (Novabiochem) to  generate  peptide  amides. 5-Carboxyfluorescein (5-FAM) 
(Chempep)  was  coupled to the  peptides  using  Lys(ivDde) (Chempep).  The ivDde 
protecting group was orthogonaly removed using standard deprotection procedures. 
The resulting  peptides  were  cleaved  using TFA/thioanisole/water/trisopropylsilane/ 
phenol (87.5:2.5:2.5:2.5:5  v/v)  and  purified with  a  Varian  Dynamax  Microsorb  C18 
preparative  column (Agilent).  Purified  peptide  was lyophilized  and its  mass  was 
confirmed  with  an  Applied  Biosystems  Voyager  DE-STR  MALDI-TOF  mass 
spectrometer (Life  Technologies). Of  note, to  obtain the H3K79me3  5-FAM-linked 
peptide, it  was  necessary to instal  Fmoc-(FmocHmb)Phe-OH (Novabiochem)  at 
F84. Peptides were synthesized and purified by Dr. Blair C.R. Dancy.    
2.2K Fluorescence Polarization Assays 
Binding  assays  were  performed  as previously described with the folowing 
modifications234.  Ful-length wild type  Pdp3,  F18A,  and  W21A  proteins  were 
exchanged into  FP  bufer (50  mM  Tris  pH  7.5,  150  mM  NaCl,  5  mM  DTT)  and 
concentrated to  ~260-430  µM  using  Amicon  Centrifugal  Filter  Units  MWCO  30,000 
(Milipore). Binding assays were performed in a 60 µL volume with 96 wel half area 
black flat  botom  non-binding  surface  plates (Corning).  Protein  was  serialy  diluted 
with  FP  Bufer in  2-fold increments  and incubated  with  120  nM  of  5-FAM-labeled 
histone peptides. Folowing a 30 min equilibration period, fluorescence was detected 
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at room temperature with  an Infinite  M1000  plate reader (Tecan)  using  a  470  nm 
excitation filter  and  527±  20  nm  emission filter.  Binding  curves  were  analyzed  by 
Prism 5.0 (GraphPad Inc.), using the total binding equation Y= Bmax* X / (Kd + X) + 
NS *  X  +  Background,  where  Bmax=  1  and  non-specific (NS)  and  background 
variables  are  constrained to be  equal  between  peptides.  Eror  bars represent the 
standard  deviation of  a representative  experiment (n=  2)  performed in triplicate. I 
would like to  acknowledge  Dr.  Jungsan Sohn  and  Seamus  Morone for technical 
assistance with FP assays and data analysis. 
2.2L Chromatin Association Assays 
Strains  were  grown in  YPD to an  OD  of  ~0.8-1. 40-50 total ODs  of  cels  were 
washed in SB bufer (1 M Sorbitol, 20 mM Tris.Cl pH 7.4), frozen in liquid nitrogen, 
and stored at −80 °C. Cels were resuspended in 1 mL of PSB bufer (20 mM Tris pH 
7.4, 2 mM EDTA, 100 mM NaCl, 10 mM β-ME). 1 mL of SB bufer was then added 
and cels were spheroplasted with Zymolyase (Seikagaku Biobusiness) for 30 min at 
room temperature. Spheroplasts were peleted at 2,000 x g and washed twice with 
LB bufer (0.4 M Sorbitol, 150 mM potassium acetate, 2 mM magnesium acetate, 20 
mM  PIPES  pH  6.8).  TritonX-100  was  added to a final  concentration  of  1%. Cels 
were lysed for  15  min on ice.  Chromatin  was peleted at  5,000  x g for  15  min. 
Supernatant  was  colected  and  saved  as the “soluble” fraction. Chromatin  was 
washed one time with LB bufer and resuspended in an equal volume to that of the 
“soluble” fraction.  Volume  equivalents  were resolved  on  15%  SDS-polyacrylamide 
gels, transfered to PVDF, and probed with antibodies recognizing Protein A (Sigma 
Aldrich),  G6PDH (Sigma  Aldrich), and H4 (Abcam:  ab10158). Immunoblots  were 
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visualized using HRP-conjugated secondary antibodies and ECL Prime solution (GE 
Healthcare). Yeast strains were created by Stephen L. McDaniel in the laboratory of 
Dr.  Brian  D. Strahl  at the  University  of North  Carolina  at  Chapel  Hil. Stephen L. 
McDaniel  also  performed  al  chromatin fractionation assays  and the associated 
western  blots. I  would like to acknowledge Dr.  Brian D. Strahl  and  Stephen L. 
McDaniel for their immeasurable contributions to this project. 
 
2.3 Results 
2.3A Pdp3 is a Member of the NuA3 HAT Complex 
Eaf6,  Nto1,  Sas3,  Taf14,  and  Yng1  were  previously identified  as  stable 
members  of the S.  cerevisiae NuA3  HAT  complex55,104-106. A  non-stable  NuA3-
associated protein, Pdp3 (Ylr455w), was also detected using isotopic diferentiation 
of interactions  as random  or targeted (I-DIRT) mass  spectrometry55,116. Pdp3 
contains  a  PWWP  domain conserved with BRPF1,  a  member  of the NuA3 H. 
sapiens homolog complex, MOZ/MORF66,92,111.  Therefore,  we reasoned that Pdp3 
might function  similarly to the  PWWP  domain of  BRPF1 in the  NuA3  complex. 
Endogenously TAP-tagged  Pdp3  was isolated from S. cerevisiae using  a  method 
that preserves complex integrity115,116. Proteins co-purifying with Pdp3 were resolved 
by SDS-PAGE and subjected to tandem MS analysis. Pdp3 interacts with al stable 
members  of  NuA3 (Eaf6,  Nto1,  Sas3,  Taf14,  Yng1),  core histones (H2A,  H2B,  H3, 
H4),  and  components  of  RNAPI (Rpb2,  Rpb4)55,104-106 (Figure 7A). Although this 
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Figure 7 Pdp3 is associated with the NuA3 HAT complex, chromatin, and 
RNAPI. A.) Spectral counts are reported for endogenous S. cerevisiae proteins 
afinity purified by Pdp3-TAP, after searching with Mascot. This experiment was 
performed by Dr. Stephanie D. Byrum in the laboratory of Dr. Alan J. Tacket at the 
University of Arkansas for Medical Sciences. B.) Whole cel extracts (WCEs) from 
the indicated TAP-tagged yeast strains were immunoprecipitated with HIS6X-
FLAG-Pdp3 treated (+) and untreated (-) Ni-NTA resin. WCEs (inputs) and 
immunoprecipitated samples (IP) were resolved by SDS-PAGE. The presence of 
NuA3 complex members was monitored by western bloting to TAP and FLAG.  
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purifications  suggest that  Pdp3 is  a member of the  NuA3  complex  and that  Pdp3 
functions in the transcriptional regulation pathway.   
To confirm that Pdp3 is a member of NuA3, we tested the ability of ful-length 
recombinant Pdp3 to  pul  down  NuA3  proteins from  celular  extract. Pdp3 was 
incubated  with lysates from S. cerevisiae expressing endogenously TAP-tagged 
NuA3  subunits. Immunoprecipitated  samples  were resolved  by  SDS-PAGE  and 
visualized by western bloting. Pdp3 interacts with Yng1, Nto1, and Sas3, supporting 
our MS results (Figures 7A, 7B). Taf14 was not detected in Pdp3 pul downs, which 
may indicate that these proteins do not directly interact or that the TAP tag on Taf14 
disrupts binding (Figure 7B). 
2.3B Pdp3 Specificaly Engages H3K36me3  
H3K36me3 localizes to the  ORFs of  actively transcribed  genes and is 
associated  with transcription  elongation32,33,61,62,218,219,222. The  PWWP  domain  of H. 
sapiens BRPF1 specificaly engages H3K36me392,111 (Figure 8A). Importantly, this 
PWWP  domain is required for the recruitment of MOZ/MORF to H3K36me3-
enriched HOX  genes and for HOX  gene transcription88,92. In S. cerevisiae, the 
histone-binding domains  of  BRPF1 (PWWP  domain, double  PHD fingers,  double 
bromodomains)  are  split  between  Pdp3 (PWWP  domain)  and  Nto1 (double  PHD 
fingers,  double  bromodomains)111,117. Structural  modeling  predicts that the  PWWP 
domain  of Pdp3  contains conserved aromatic residues  critical for  methyl-lysine 
binding  and  conserved  secondary  structure with  PWWP domains that  bind 
methylated histones (Figures 8B, 9A, 9B). Therefore, we reasoned that like BRPF1, 























Figure  8  The  Pdp3  PWWP  domain is  structuraly  conserved  with  human 
BRPF1. A.)  Crystal  structure  of the H.  sapiens  BRPF1  PWWP  domain (purple) 
bound to H3K36me3 peptide (pink) (PDB: 2X4W)92. B.) The predicted structure of 
the yeast Pdp3 PWWP domain (brown) bound to H3K36me3 peptide (pink). Note 
that  Pdp3 is  predicted to  have  conserved  aromatic residues (yelow).The  Pdp3 
structure was modeled on 2X4W using Phyre2, minimized with MOE, and rendered 






β1 β2 β3 β4 
s.c.Pdp3(5-60)IRTGDLVLCKVGSFPPWPAVVFPQRLLRNDVYRKR----KSNCVAVCFFNDPTYYWE--
h.s.BRPF1     LDALDLVWAKCRGYPSYPALIIDPKMPREGMFHHG-(23)-HLYLVLFFDNKRTWQWLP
h.s.MSH6      FSPGDLVWAKMEGYPWWPCLVYNHPFDGTFIREKGK----SVRVHVQFFDDSPTRGWVS
h.s.DNMT3b    FGIGDLVWGKIKGFSWWPAMVVSWKATSKRQAMS-------GMRWVQWFGDGKFSEISA
h.s.HDGF2     FKPGDLVFAKMKGYPHWPARIDDIADGAVKPPPN--------KYPIFFFGTHETAFLGP
s.p.Pdp1      LNFGDRILVKAPGYPWWPALLLRRKETKDSLNTNSS---FNVLYKVLFFPDFNFAWVKR
s.c.Ioc4      FQPTDIVLAKVKGFSAWPAMIIPNELIPDNILKTK-(68)-STYCVKFFCDDSYIWVKP
s.c.Pdp3(61-105) -RLKELDQDSIHNFILEHSKNANQRELVNAYKEAKNFDDFNVFLQE
h.s.BRPF1        RTKLVPLGVNQDLDKEKMLEGRKSNIRKSVQIAYHRALQHRSKVQG
h.s.MSH6         KRLLKPYTGSKSKEAQKGGHFYSAKPEILRAMQRADEALNKDKIKR
h.s.DNMT3b       DKLVALGLFSQHFNLATFNKLVSYRKAMYHALEKARVRAGKTFSSS
h.s.HDGF2        KDLFPYDKCKDKYGKPNKRKGFNEGLWEIQNNPHASYSAPPPVSSS
s.p.Pdp1         NSVKPLLDSEIAKFLGSSKRKSKELIEAYEASKTPPDLKEESSTDL
s.c.Ioc4         MDMKILTSEDCRKWLSGKQRKNKKLIPAYEMAMRGKNGIDIWEFVE
β5 α1 α2 
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Figure 9 The Pdp3 PWWP domain shares conserved sequence and 
secondary structure with yeast and human PWWP domain proteins. A.) 
Clustal W alignment of S. cerevisiae, S. pombe, and H. sapiens PWWP domains. 
Beta sheets (blue arows/underlined sequence) and alpha helices (grey cylinders/
underlined sequence) are annotated. Aromatic “cage” residues are highlighted in 
yelow. B.) Schematic representation of the Pdp3 protein. The predicted (red 
outline) and functional (tan hexagon) PWWP domains are annotated. Aromatic 
cage residues are highlighted in yelow. 
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To determine if  Pdp3  engages  H3K36me3,  we tested the  ability  of histone 
peptides to  pul  down ful-length  Pdp3. Biotinylated  peptides  were immobilized  on 
streptavidin resin  and incubated  with Pdp3. Immunoprecipitated  samples  were 
resolved by SDS-PAGE and visualized by western bloting. Pdp3 preferentialy binds 
H3K36me3 peptide  over  al tested trimethylated and  unmodified  peptides (Figure 
10A). 
 
2.3C  Pdp3  Requires  a Conserved Aromatic “Cage” for Binding 
H3K36me3 
 
PWWP domains use an aromatic “cage” to interact with specific trimethylated 
lysine residues49,70,71,92,98,235.  For  example,  BRPF1 requires  aromatic residues 
Y1096,  Y1099,  and  F1147 to  coordinate the trimethylammonium  group  of 
H3K36me3 (Figure 8A)92.  These  aromatic residues  are  conserved in the  PWWP 
domain of Pdp3 at positions F18, W21, and F48 (Figures 8B, 9A, 9B). To determine 
whether  Pdp3  uses  an  aromatic “cage” to bind  H3K36me3,  we tested the  ability  of 
H3K36me3  peptide to  pul  down ful-length Pdp3  mutants F18A,  W21A,  or  F48A. 
Each  mutation independently blocks the interaction  between  Pdp3 and  H3K36me3 
peptide,  suggesting  Pdp3 requires  a  conserved  aromatic “cage” to  bind histones 
(Figure 10B). 
2.3D The  PWWP Domain of Pdp3 is Necessary  and Sufficient for 
Binding H3K36me3 
 
 We next wanted to determine whether the predicted PWWP domain of Pdp3 
is suficient to  maintain an interaction  with H3K36me3. Uniprot  defined the Pdp3 













Figure 10 Pdp3 specificaly interacts with H3K36me3 through a conserved 
PWWP domain. A.) Peptide pul down assays were performed with ful-length 
FLAG-Pdp3 and biotinylated histone peptides. Purified protein (input) and 
immunoprecipitated samples (IP) were resolved by SDS-PAGE. Binding was 
monitored by western bloting to FLAG and streptavidin. B.) Peptide pul down 
assays were performed with FLAG-tagged ful-length Pdp3, mutants: F18A, W21A, 
and F48A, truncations: PWWP(1-74), PWWP(1-110), PWWP(2-150), PWWP(1-219), and C-
term(74-304), and biotinylated histone peptides. Purified proteins (inputs) and 
immunoprecipitated samples (me0 and me3) were resolved by SDS-PAGE. 





































segment  of  Pdp3 (PWWP(1-74) is  unable to bind  H3K36me3  peptide (Figure 10B). 
Our results  suggest that residues  beyond the  predicted  PWWP  domain  are 
necessary for Pdp3 function. Like BRPF1, our modeled Pdp3 structure contains two 
alpha helices proximal to the aromatic “cage” (Figures 8A, 8B)92. These  alpha 
helices may stabilize the PWWP domain and hold the aromatic “cage” in a position 
that is favorable for histone binding. To test our hypothesis, we created a series of 
Pdp3 constructs that include increasing segments of the modeled alpha helices. We 
assayed the  ability  of  H3K36me3  peptide to  pul  down  PWWP(1-110), PWWP(2-150), 
and PWWP(1-219). PWWP(2-150) restores  binding to  H3K36me3  and thus represents 
the functional PWWP domain of Pdp3 (Figures 9B, 10B). These data suggest Pdp3, 
and likely  other  PWWP  domain  proteins, require unannotated alpha helices for 
aromatic “cage” stability and function. 
2.3E Biophysical Characterization of the Interaction between Pdp3 
and H3K36me3 
 
To biophysicaly quantitate the specificity of the interaction between Pdp3 and 
H3K36me3,  we  performed fluorescence  polarization  assays  using ful-length 
Thioredoxin-HIS6X-S•tag-Pdp3  and 5-FAM-labeled  histone  peptides. In  agreement 
with  our  peptide  pul down  assays,  Pdp3 favors  binding to H3K36me3  over  other 
known targets  of  PWWP  domain  proteins,  such  as  H3K79me3  and  H4K20me3 
(Figures 11A, 11B). Pdp3 engages H3K36me3 peptide with a Kd of 69.5 ± 3.7 µM 
(Figure 11B)86,99.  Notably, this  value is  one  of the lowest reported  dissociation 
constants for  PWWP  domains  and  methylated  histones86,91,92,99,237. As  PWWP 
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Pdp3  Peptide Kd(μM) 
 WT  H3K36me3  69.5 +/- 3.7 
 WT  H3K36me2  414 +/- 23 
 WT  H3K36me1  >>1000 
 WT  H3K36me0  >>1000 
 WT  H3K4me3  >>1000 
 WT  H3K79me3  434 +/-49 
 WT  H4K20me3  >>1000 
F18A  H3K36me3  667 +/- 68 
W21A  H3K36me3  703 +/- 73 
A  B  
Figure 11 Pdp3 specificaly interacts with H3K36me3 peptide with a Kd of 69.5 
μM. A.) Fluorescence polarization assays were used to measure binding afinities 
of ful-length wild type Stag-Pdp3 to the indicated 5-FAM-labeled histone peptides. 
Ful-length F18A and W21A mutants were also tested. Eror bars represent the 
standard deviation of a representative experiment (n= 2) performed in triplicate. B.) 
The total binding equation was used to calculate dissociation constants with 
Graphpad Prism software. Kd values were tabulated from two independent 
experiments performed in triplicate and averaged. Eror represents the standard 
deviation of two independent experiments. 
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We then tested Pdp3 mutants, F18A  and  W21A, which  are predicted to 
disrupt the  aromatic “cage” required for  H3K36me3  binding. F18A  and  W21A 
mutations reduce H3K36me3 peptide binding ~10 fold compared to wild type, further 
supporting our peptide pul down results (Figures 10B, 11A, 11B). Pdp3 also weakly 
binds H3K36me2  peptide  with  a Kd of  ~414  µM (Figures 11A, 11B). The  ~6 fold 
increase in specificity of Pdp3 for H3K36me3 (over H3K36me2) suggests that Pdp3 
has  a  distinct function from complexes that  preferentialy  bind  H3K36me2,  such  as 
the transcriptionaly repressive Rpd3S HDAC complex223,226,229,238,239. 
2.3F Pdp3 Requires H3K36me3 to Bind Chromatin In Vivo 
To further  understand the function  of  Pdp3,  we determined  whether  Pdp3 
binds  H3K36me3 in  vivo through  a  chromatin  association  assay that separates 
soluble and chromatin-bound proteins. The H3K36me3 HMT, SET2, was deleted in 
the PDP3-TAP background. The H3K4me3 HMT, SET1, and the NuA3 H3K4me3-! 
binding protein, YNG1, were also deleted in the PDP3-TAP background. Strikingly, 
in the absence of H3K36me3, Pdp3 does not bind chromatin, indicating H3K36me3 
is  critical for  Pdp3 localization in  vivo (Figure 12A). In  contrast,  Pdp3 binds 
chromatin in the  absence  of both  H3K4me3 and  Yng1, indicating Pdp3 directly 
targets NuA3 to ORFs via an interaction with H3K36me333,53,65 (Figure 12A). 
 SET1,  SET2, and PDP3 were then  deleted in the YNG1-TAP background. 
Yng1 remains  bound to  chromatin in the  absence  of H3K4me3, H3K36me3,  and 
Pdp3 (Figure 12B).  This  suggests that  while  Yng1  can  engage  chromatin through 
methyl-independent  means (such  as the Yng1  N-terminus  or  Pdp3), Pdp3 requires 


















































































































Figure 12 Pdp3, but not Yng1, requires H3K36me3 for chromatin association 
in vivo. A.) TAP-tagged PDP3 S. cerevisiae strains and B.) TAP-tagged YNG1 S. 
cerevisiae strains were biochemicaly fractionated into chromatin-associated 
proteins and soluble proteins. Fractions were probed for the presence of Pdp3 and 
Yng1  via the TAP tag.  G6PDH (soluble)  and  histone  H4 (chromatin-bound)  serve 
as both loading and fractionation controls. These experiments were performed by 
Stephen  L.  McDaniel in the laboratory  of  Dr.  Brian  D. Strahl  at the  University  of 





Here  we  define  Pdp3  as  a novel member  of the  NuA3  HAT  complex. Ppd3 
specificaly interacts  with  H3K36me3 in  vitro and in  vivo, through  a  structuraly 
conserved  PWWP  domain, and recruits  NuA3 to  H3K36me3-enriched  chromatin. 
Therefore,  we  propose  a  new function for H3K36me3 in  yeast- H3K36me3  may 
positively regulate transcription via  HAT  complex recruitment into ORFs. Until our 
study,  only  negative regulatory functions  have  been  described for  H3K36me3 in 
yeast, such  as  HDAC recruitment  and  blockage  of trans-histone  exchange20,63-
65,223,224. In Chapter 3 we  continue to  elucidate the  positive role of  Pdp3 in 
transcriptional regulation. 
 Mutations  of the NuA3 human  homolog, MOZ/MORF, are  associated  with 
multiple types  of  cancer92,111,152-154,240. For  example,  MOZ fuses to the  HAT 
p300/CBP, resulting in aberant acetylation and HOX gene overexpression151,155-159. 
HOX  gene  overexpression causes hematopoietic  stem  cel transformation  and 
leukemogenesis8,160. Since MOZ fusions  assemble into the  MOZ  HAT  complex, 
inhibition  of associated histone-binding “reader”  domains  may  provide new 
treatments for leukemia8,88,92,158. Indeed, the PWWP domain of the BRPF1 subunit is 
required for  MOZ/MORF localization  and  HOX  gene transcription88,92. Therefore, 
smal molecules targeting the aromatic “cage” within the BRPF1 PWWP domain may 
aleviate  pathogenesis92. Additionaly,  our  studies  on the yeast homolog,  Pdp3, 
reveal a  novel  characteristic  of  PWWP  domains. We find that PWWP domains 
require  unannotated alpha helices for  aromatic “cage” stability  and function. 
Therefore, it may be possible to inhibit PWWP domain binding by destabilizing these 
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alpha helices using constrained  peptides  and  proteomimetics,  which have  shown 
recent promise in blocking helix-mediated interactions241. Future mechanistic studies 
into the PWWP domain of Pdp3 may further clarify how efector proteins contribute 

















Chapter 3 The NuA3 HAT Complex Exists in 
Two Functionaly Distinct Forms that 
Coordinate Transcription Initiation and 
Elongation Pathways 
 
This research  was  originaly  published in Molecular  and  Celular 
Proteomics. Tonya  M.  Gilbert,  Stephen  L.  McDaniel,  Stephanie  D. 
Byrum,  Jessica  A.  Cades,  Blair  C.  R.  Dancy,  Herschel  Wade,  Alan  J. 
Tacket,  Brian  D.  Strahl,  and  Sean  D.  Taverna. A  PWWP  Domain-
Containing  Protein  Targets the  NuA3  Acetyltransferase  Complex  via 
Histone  H3  Lysine  36 Trimethylation to  Coordinate  Transcriptional 
Elongation at Coding Regions. Molecular and Celular Proteomics. 2014; 





The  access  of transcriptional  machinery to  DNA is  dependent on chromatin 
structure5,206. Chromatin  structure is regulated in  part by  chromatin-associated 
protein complexes that  modulate  histone  post-translational  modifications 
(PTMs)13,17,19,20. Histone  PTMs  are found throughout the  genome in  a  context 
dependent  manner13,19,23,31-33,53,210 (Figure  2B). For  example,  histone  H3 is  often 
both trimethylated on lysine 4 (H3K4me3) and acetylated on lysine 14 (H3K14ac) at 
the  5’-ends  of transcriptionaly  active genes23,31-33,53,54. Alternatively,  H3K36me3 is 
found throughout the  open reading frames (ORFs) of active genes32,33,53,209. The 
conserved S.  cerevisiae NuA3  histone  acetyltransferase (HAT)  complex  can 
modulate its localization  and function  by  engaging these  diferentialy  positioned 
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histone PTMs55,104-108,110. NuA3 binds  H3K4me3 through the  plant  homeodomain 
(PHD) finger of the Yng1 subunit55,106-108 (Figure  5A). NuA3 then acetylates H3K14 
and initiates transcription  at  a  subset  of  genes through recruitment  of the  histone 
chaperone,  FACT,  and the  chromatin-remodeler, RSC43,44,55,105,106 (Figure  5A). 
NuA3  also binds  H3K36me3 through the proline-tryptophan-tryptophan-proline 
(PWWP) domain of Pdp3 (Ylr455w) (See Chapter 2).  
In yeast,  H3K36me3 is  corelated specificaly with the regulation  of 
transcription  elongation61,62,218,219,222. H3K36me2/3 recruits the histone  deacetylase 
(HDAC) complex,  Rpd3S, which generates  a  hypoacetylated  environment  behind 
elongating  RNAPI to represses intergenic transcription223-229. We find that 
H3K36me3  also recruits the  NuA3  HAT  complex into  coding regions, for  an 
undetermined function (See Chapter 2).  As  other S.  cerevisiae HAT  complexes, 
such  as  NuA4  and  SAGA,  coordinate  nucleosome  eviction  at  ORFs through the 
acetylation of histones H3 and H4, we hypothesize that NuA3 may similarly facilitate 
transcription elongation and oppose Rpd3S HDAC activity242-244. 
Here, using biochemical and genetic analyses,  we classify  NuA3 into two 
functionaly distinct forms: NuA3a and NuA3b. NuA3a uses the PHD finger of Yng1 
to  bind  H3K4me3  at the  5’-ends  of ORFs  and initiates transcription through the 
acetylation of H3K14. NuA3b uses the PWWP domain of the unique member, Pdp3, 
to  bind  H3K36me3 throughout ORFs.  We find that  deletion  of PDP3 decreases 
NuA3-directed transcription  and results in  growth  defects  when  combined  with 
transcription elongation mutants, suggesting NuA3b positively regulates transcription 
elongation. We also determine that NuA3a, but not NuA3b, is syntheticaly lethal with 
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a deletion of the HAT, GCN5. This indicates that NuA3b has a role at ORFs that is 




3.2A Primer Sequences 
Primers were designed by Primer3 to target the 5’-end of our genes of interest. Al 
primer sequences used in Chapter 3 are listed in Table 4. 
3.2B S. cerevisiae Strains 
Al strains used in Chapter 3 are described in Table 5. 
3.2C S. cerevisiae Plasmids 
Al constructs used in Chapter 3 are described in Table 6. 
3.2D Relative Transcript Levels 
Total  RNA  was  prepared via  Trizol (Life  Technologies) from endogenously TAP-
tagged S.  cerevisiae strains: YNG1, PDP3, PDP3;yng1∆,  and YNG1;pdp3∆. DNA 
was digested with Turbo DNase (Life Technologies). cDNA was synthesized with the 
Superscript II First Strand Synthesis System (Invitrogen) and diluted 1:20 for qPCR 
analysis. Samples  were  stored  at −20 °C. Diferences in transcript levels were 
measured by qPCR using Power SYBR Green PCR Master Mix (Life Technologies) 
and a Real Time PCR system (Applied Biosystems v2.1). Relative transcript levels 






Primers used in Chapter 3 
Source: T. Gilbert, S. Taverna Lab  
Name Sequence 
YER124c F  ATTTTTCGTCAGCCTGCTATT 
YER124c R  TCAACACCGTACAGTTTCCAA 
YLL013c F  TCTTCAAGAAAACCGCCCTA 
YLL013c R  AGTAAACGGGACCAGCAATG 
YML062c F  ACCAAGCTGACAGGAAGCAT 
YML062c R  TTGGCATGTTTCCCAATTTT 
YGR157w F  ATTTCGCCAGTTTGTCGATT 
YGR157w R  AATCTTTAACCACGCGATGC 
Actin F  CTCCGTCTGGATTGGTGGTT 
Actin R  TGGACCACTTTCGTCGTATTCTT 
SSA1 F  AAGAACTTTACCCCAGAACAAATCT 
SSA1 R  TCGTTAATAATACGCAAGACATTCA 
SSB1 F  AATCTGTTCAAAAGGACATGAAGAC 




S. cerevisiae strains used in Chapter 3 
Strain Genotype Source 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 [pRS316] 
S. McDaniel, 
B. Strahl Lab 
set2∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 set2Δ:natMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
eaf3∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 eaf3Δ:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
rco1∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 rco1Δ:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
yng1∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 yng1Δ:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
pdp3∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 pdp3:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
nto1∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 nto1Δ:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
sas3∆ 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 sas3Δ:kanMX 
[pRS316] 
S. McDaniel, 
B. Strahl Lab 
Bur1 Shufle 




Bur1 Shufle; rco1∆ 
MATa bur1Δ:HIS3 rco1Δ:KanMX ura3-52 leu2Δ1 
trp1Δ63 his3Δ200 lys2Δ202 [pRS316-Bur1] 
M. Keogh 
Lab 
Bur1 Shufle; set2∆ 
MATα, bur1Δ:HIS3, set2Δ:KanMX, ura3-52 or 3Δ0, 





Bur1 Shufle; yng1Δ 
MATa bur1Δ:HIS3 ura3-52 leu2Δ1 trp1Δ63 his3Δ200 
lys2Δ202 yng1∆:natMX [pRS316-Bur1] 
S. McDaniel, 
B. Strahl Lab 
Bur1 Shufle; pdp3Δ 
MATa bur1Δ:HIS3 ura3-52 leu2Δ1 trp1Δ63 his3Δ200 
lys2Δ202 pdp3∆:kanMX [pRS316-Bur1] 
S. McDaniel, 
B. Strahl Lab 
Bur1 Shufle; rco1∆ yng1∆ 
MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2Δ202 
bur1Δ:HIS3 rco1Δ:kanMX yng1Δ:natMX 
S. McDaniel, 
B. Strahl Lab 
Bur1 Shufle; rco1∆ pdp3∆ 
MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2Δ202 
bur1Δ:HIS3 rco1Δ:kanMX pdp3Δ:natMX 
S. McDaniel, 
B. Strahl Lab 
gcn5∆ 





MATa leu2Δ0 met15Δ0 ura3Δ0 pdp3Δ:Nat 
gcn5Δ:KanMX [pMK144] 
S. McDaniel, 
B. Strahl Lab 
gcn5∆ yng1∆ 
MATa leu2Δ0 met15Δ0 ura3Δ0 pdp3Δ:Nat 
gcn5Δ:KanMX [pMK144] 
S. McDaniel, 




S. cerevisiae plasmids used in Chapter 3 
Source: M. Kuo Lab 
Name Description 
pMK120 CUP1-pr URA3 
pMK144 CUP1-pr URA3 GCN5 
pMK144 E/H CUP1-pr URA3 GCN5 E175H 
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standard curve method. Actin was used to normalize the amount of starting template 
between  samples. Eror bars represent the standard  eror  of the  mean of  a 
representative  experiment (n=4) performed in triplicate.  Statistical  significance  was 
determined by an unpaired two-tailed t-test. I would like to acknowledge Dr. Karen L. 
Reddy,  Teresa R. Luperchio,  and  Dr.  Kimberly  Stephens for their technical 
assistance with qPCR experiments and data analysis. 
3.2E Yeast Strains and Cel Spotting Assays 
S.  cerevisiae strains  were  created  using  heterologous  gene replacement245. BUR1 
delete shufle strains were grown on synthetic complete (SC) -Ura plates to maintain 
the  wild type BUR1 plasmid  prior to  plating  on  5-Fluoroorotic  acid (5-FOA) treated 
medium246. For cel spoting assays, either 0.5 or 2 ODs of cels were 5-fold serialy 
diluted, spoted onto the appropriate plates, and incubated at 30 °C for 2-3 days as 
indicated. Yeast  strains/plasmids were  created  by Stephen L. McDaniel in the 
laboratory  of  Dr.  Brian  D.  Strahl at the  University  of North  Carolina  at  Chapel  Hil. 
Cel spoting  assays  were  also  performed  by Stephen L. McDaniel. I  would like to 
acknowledge  Dr.  Brian D. Strahl  and  Stephen L. McDaniel for their immense 
contributions to this project. 
3.2F In Vitro HAT Assays 
HAT  assays  were  performed  as  previously  described with the folowing 
modifications247.  Purifications of endogenously TAP-tagged S. cerevisiae NuA3a 
(YNG1;pdp3∆) and  NuA3b (PDP3) were performed to  maintain  complex 
integrity115,116. NuA3a and NuA3b were resuspended in HAT bufer (20 mM Tris pH 
7.5, 50 mM NaCl, 5% glycerol) and mixed with 1 µg of recombinantly expressed S. 
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cerevisiae histone H3 and 30 µM acetyl CoA in a total volume of 60 µL. Acetyl CoA 
was omited from the negative control reactions. Al reactions were incubated for 30 
min at 30 °C and frozen in liquid nitrogen. Samples were lyophilized and separated 
by acid urea gel electrophoresis as previously described248. Gels were stained with 
Simply Blue  Safe  Stain (Invitrogen).  Recombinant  histone  H3  was  obtained from 
Anne M. Cieniewicz. HAT reactions  and  acid  urea  gel electrophoresis  were 
performed by Anne M. Cieniewicz. 
 
3.3 Results 
3.3A Pdp3 is Required for NuA3-Regulated Transcription  
Mutation  of the  Yng1  PHD finger results in  genome-wide  mislocalization  of 
NuA3 from  promoter regions to ORFs, decreased  H3K14ac, and  decreased 
transcription of NuA3-regulated genes55. Since Pdp3 recruits NuA3 into ORFs via an 
association with H3K36me3, Pdp3 may also participate in transcriptional regulation. 
To further  assess the function  of  Pdp3 in  vivo,  we  performed  RT-qPCR  with  wild 
type, pdp3∆,  and yng1∆ cels. We calculated the % transcription for  each  mutant 
relative to wild type. As expected, yng1∆ cels show a significant decrease in the % 
transcription of  NuA3 target  genes, confirming a  positive role for  Yng1 in  NuA3 
activity55 (Figure 13). Interestingly, pdp3∆ cels also show a significant decrease in 
the % transcription of NuA3 target genes (Figure 13). These data indicate that NuA3 



































* * * * 
Figure 13 NuA3-regulated transcription requires both Yng1 and Pdp3. RT-
qPCR analysis of WT, yng1Δ, and pdp3Δ cels to determine the relative transcript 
levels of NuA3-target genes and non-target genes (SSA1 and SSB1). Transcript 
levels were normalized to Actin expression. Eror bars represent the standard eror 
of the mean of a representative experiment (n=4) performed in triplicate. Asterisks 
indicate statistical significance as determined by an unpaired two-tailed t-test.  




3.3B PDP3 has Genetic Links to SET2 and Promotes Transcription 
Elongation 
 
Since  Pdp3  binds  H3K36me3  and is required for  proper NuA3-regulated 
transcription, Pdp3 may facilitate transcription elongation. The BUR1 bypass assay 
is  a  genetic tool that measures the influence  of  H3K36  methylation-dependent 
interactions on transcription elongation. Bur1, a cyclin-dependent kinase, acts as an 
essential positive regulator by  phosphorylating several  components  of  elongating 
RNAPI249-251. Although deletion of BUR1 is lethal, deletion of BUR1 combined with 
deletion  of SET2 or RCO1 (a  unique  member  of the Rpd3S HDAC  complex) 
bypasses lethality218,224. To explore whether Pdp3 or Yng1 contribute to transcription 
elongation,  we evaluated deletions  of PDP3 and YNG1 in the bur1∆ background. 
Neither bur1∆pdp3∆ nor bur1∆yng1∆ cels  are  viable (Figure 14A).  These results 
suggest either PDP3 and YNG1 do not function in the elongation pathway, or Pdp3 
and  Yng1 act as  positive  elongation factors and thus do not  display  a bypass 
phenotype. To distinguish between these possibilities, we created strains with PDP3 
or YNG1 deleted in the bur1∆rco1∆ background.  Since this  background  shows  a 
bypass  phenotype,  we  could  now  observe how deletion of PDP3 or YNG1 afects 
transcription elongation. Significantly, both bur1∆rco1∆pdp3∆ and bur1∆rco1∆yng1∆ 
cels show  a  decrease in  growth  as  compared to the bur1∆rco1∆ background 
(Figure 14A). Our results suggest that  Pdp3 and  Yng1  positively regulate 
transcription elongation. 
To further  connect  NuA3 to the transcription  elongation  pathway,  we 








































6-AU: Day 2 SC-Ura: Day 2 
5-FOA: Day 3 SC-Ura: Day 2 
A 
B 
Figure  14 PDP3 functions in the SET2 genetic pathway to facilitate 
transcription elongation. A.) 2 ODs of the indicated S. cerevisiae strains were 5-
fold serialy diluted on SC-Ura (left) or SC-Ura + 5-FOA (right) plates and grown at 
30 oC for two or three days, respectively. B.) 0.5 ODs of the indicated S. cerevisiae 
strains were 5-fold serialy diluted onto SC-Ura (left) or SC-Ura + 150 µg/mL 6-AU 
(right) plates and grown at 30 oC for two days. These experiments were performed 
by Stephen L. McDaniel in the laboratory of Dr. Brian D. Strahl at the University of 




inhibitor.  Strains  containing  a  deletion  of SET2, or deletions  of downstream 
H3K36me3 efectors such as RCO1 and EAF3, show a resistance phenotype218,224. 
Of al the tested  NuA3 deletions, only pdp3∆ cels display 6-AU resistance (Figure 
14B). This suggests that Pdp3 may directly regulate transcription elongation, while  
Yng1 may indirectly facilitate transcription elongation by initiating transcription. 
3.3C PDP3 is Not Syntheticaly Lethal with GCN5 
It  has  previously  been  determined that  NuA3 subunits, SAS3 and YNG1, 
display  synthetic lethality  with the  HAT, GCN5110. NuA3  and Gcn5-associated 
complexes (such as SAGA) acetylate H3K14 and localize to both promoter regions 
and  ORFs242,244,252.  Therefore, Sas3 and Gcn5 may colaborate to  promote 
transcription initiation and elongation.  Given the positive role of Pdp3 in the 
transcription  elongation  pathway,  we  wanted to  determine if PDP3 is  syntheticaly 
lethal with GCN5. We performed a GCN5 plasmid shufle assay in gcn5∆yng1∆ and 
gcn5∆pdp3∆ backgrounds.  Surprisingly, gcn5∆pdp3∆ cels  show  no  deleterious 
phenotype, indicating PDP3 does  not  geneticaly interact  with GCN5 (Figure 15). 
These results suggest that Pdp3-containing NuA3 either does not acetylate H3K14 
or that  Pdp3-directed  H3K14ac  has  a  distinct function from the role  of Gcn5  at 
ORFs. We  performed an in  vitro HAT  assay with  endogenous NuA3  complexes 
(YNG1-TAP;pdp3∆ and PDP3-TAP) and recombinant S. cerevisiae histone H3. We 
observe multiple acetylation states from each complex, suggesting Pdp3-containing 
NuA3 may target  novel  sites (Figure 16). Further  MS analysis is required to 








































5-FOA: Day 2 
Figure 15 YNG1, but not PPD3, is syntheticaly lethal with GCN5. 0.5 ODs of 
the indicated S. cerevisiae strains were 5-fold serialy diluted onto SC-Ura (top) or 
SC-Ura + 5-FOA (botom) plates and grown at 30 oC for two days. This experiment 
was performed by Stephen L. McDaniel in the laboratory of Dr. Brian D. Strahl at 







+ - + - + - Acetyl CoA 
YNG1-TAP; 
 pdp3∆  BY471 
Figure  16  Pdp3-containing  NuA3  may  acetylate  novel targets. In  vitro HAT 
assays were performed with endogenous NuA3 complexes (YNG1-TAP;pdp3∆ and 
PDP3-TAP), recombinant S. cerevisiae histone  H3,  and  acetyl  CoA.  Reactions 
were separated by acid urea gel electrophoresis and stained with Simply Blue Safe 
Stain.  The YNG1-TAP;pdp3∆ complex  acetylated three  distinct  states  and the 
PDP3-TAP  complex  acetylated four  distinct  states.  MS  analysis  wil  determine 
which histone residues each complex acetylated. HAT reactions and acid urea gel 











 Using biochemical and  genetic  approaches, we find that the S.  cerevisiae 
NuA3 HAT complex exists in two functionaly distinct forms: NuA3a and NuA3b. This 
nomenclature  has  previously  been  used to  distinguish subtypes of related 
complexes,  such  as the Isw1a  and Isw1b  ATP-dependent  chromatin remodelers. 
While these  complexes contain the  same  catalytic subunit, Isw1, Isw1b uniquely 
contains the PWWP  domain  protein, Ioc4, which targets remodeling  activity to 
H3K36me3-enriched  nucleosomes63,64. Similarly, we  hypothesize that while NuA3a 
and NuA3b contain the same catalytic subunit, Sas3, NuA3b uniquely contains the 
PWWP  domain  protein,  Pdp3.  We  predict that NuA3a  specificaly  associates  with 
H3K4me3 through the  PHD finger  of  Yng1 to  acetylate H3K14 and facilitate 
transcription initiation55,105-108 (Figure 17A).  Conversely, NuA3b  specificaly 
associates  with  H3K36me3 through the  PWWP  domain  of  Pdp3 to facilitate 
transcription elongation via an undetermined mechanism (Figure 17B). 
 Altogether our data support the model that NuA3b is compositionaly distinct 
from NuA3a55. However, we cannot exclude the alternative possibility that Pdp3 is a 
member  of  both  NuA3a  and  NuA3b. Pdp3  activity  may  be  alostericaly  modulated, 
alowing  NuA3b to  bind  H3K36me3 in  a  context  dependent  manner.  Notably, the 
conserved human BRPF1  protein resembles a fusion  of  yeast  Nto1 and  Pdp3146. 
Therefore, in  order for  yeast  NuA3a/b  and  human  MOZ/MORF  HAT  complexes to 
display  similar  genomic localization paterns, the  BRPF1  PWWP  domain may  be 
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Figure 17 The NuA3 HAT complex exits in two functionaly distinct forms that 
facilitate transcription. A.) Model of the NuA3a HAT complex66. NuA3a binds 
H3K4me3 at promoter regions through the PHD finger of Yng155,107,108. Sas3 then 
acetylates H3K14, leading to transcription initiation of a subset of genes55,104-106. 
B.) Model of the NuA3b HAT complex66. NuA3b contains a unique member, Pdp3. 
NuA3b binds H3K36me3 at ORFs through the PWWP domain of Pdp3 to positively 
regulate transcription elongation. Although the function of NuA3b in the elongation 
pathway is not fuly defined, we speculate that Sas3 may acetylate histones or non-






We find that  Pdp3,  and thereby NuA3b,  positively regulate transcription 
elongation,  yet the  mechanism of NuA3b activity remains unclear.  Since  NuA3-
directed transcription is  decreased in pdp3∆ cels,  NuA3b may participate in 
acetylation-dependent nucleosome eviction, similar to the proposed function of Gcn5 
at ORFs242-244,253. However, PDP3 is not syntheticaly lethal with GCN5, suggesting 
NuA3b may  acetylate  a  diferent  histone residue  or  a  non-histone  protein to  signal 
for transcription  elongation (Figure 17B). Interestingly, a related  human  HAT 
complex, HBO1, can  switch  between histone H4  and  H3  acetylation  depending  on 
the association of JADE versus BRPF subunits254. Although speculative, NuA3b may 
similarly change HAT specificity with the addition of Pdp3. Future work is needed to 
determine the mechanism of NuA3b activity in the transcription elongation pathway. 
Finaly,  how specific  histone PTMs regulate transcription remains  an 
important  question in  chromatin  biology. For  example,  although  H3K36me2  and 
H3K36me3  are  both linked to transcription elongation, these  marks are  associated 
with diferent functions20,209,217. In  yeast H3K36me2  suppresses intergenic 
transcription via  HDAC complex recruitment,  while H3K36me3 facilitates 
transcription  elongation  via  HAT  complex recruitment223,224,228,232. We propose that 
diferential methyl states of H3K36 may act as a “switch” to regulate the progression 
of  RNAPI.  For  example,  on lowly transcribed  genes, the  H3K36me2  state  may 
predominate  and recruit  Rpd3S to  maintain  a repressive chromatin environment. 
Conversely, on highly transcribed genes, the H3K36me3 state may predominate and 
recruit NuA3b (and other HATs such as NuA4) to facilitate nucleosome disruption in 
front  of  elongating  RNAPI232. Alternatively, H3K36me2  and H3K36me3  may 
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coordinate HDAC  and  HAT  activities within the  same ORF to  modulate transcript 





















Chapter 4: The Conserved ET Domain of Taf14 
Mediates an Interaction with Yng1 and is 




Chromatin  acts  as  a  barier to  multiple  celular  processes, including 
transcription16. Therefore,  nucleosome  organization  provides a mechanism for the 
regulation of gene expression17. Nucleosome organization is coordinated in part by 
chromatin-associated  protein  complexes that modulate  histone post-translational 
modifications (PTMs)19,20. These  complexes  often  contain  both an enzymatic 
subunit(s)  and  an  efector  protein(s) that  binds  specific histone  PTMs, alowing for 
the precise targeting of chromatin-templated activity13,17,19,21,49,73,98. 
Histone PTMs are deposited throughout the genome in a context dependent 
manner13,19,23,33,53,210 (Figure  2B). For  example,  histone  H3 is  often  both 
trimethylated on lysine 4 (H3K4me3) and acetylated on lysine 14 (H3K14ac) at the 
5’-ends  of transcriptionaly  active  genes23,31-33,52,53,133.  Alternatively,  H3K36me3 is 
found throughout the open reading frames (ORFs) of expressed genes32,33,53,209. The 
conserved S.  cerevisiae NuA3  histone  acetyltransferase (HAT)  complex  can 
modulate its localization and function by engaging (“reading”) and adding (“writing”) 
these  diferentialy  positioned histone  PTMs55,66,104-108,110.  NuA3a specificaly  binds 
H3K4me3 through the  plant  homeodomain (PHD) finger  of the  Yng1  subunit55,107 
(Figure 17A).  NuA3a then  acetylates  H3K14, leading to transcription initiation  at  a 
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subset of genes55,105,106 (Figure 17A). NuA3b contains the unique member, Pdp3, a 
proline-tryptophan-tryptophan-proline (PWWP)  domain  protein66 (Figure  17B). 
NuA3b binds H3K36me3 through the  PWWP  domain  of  Pdp3 to facilitate 
transcription elongation66 (Figure 17B). 
In addition to Yng1 and Pdp3, NuA3 contains other efector proteins, including 
the YEATS (named for Yaf9, ENL, AF9, Taf14, and Sas5) domain protein, Taf14105. 
Taf14 is a subunit of multiple chromatin-associated complexes (TFID, TFIF, Ino80, 
SWI/SNF,  RSC,  Mediator,  and  NuA3)  and  has links to transcription initiation, 
transcription  elongation,  cel  cycle  progression,  cytoskeletal-organization,  post-
replication repair,  and  chromosome  stability104,105,118-132,140-143,255. While it is  known 
that  C-terminal residues  124-244  are required for Taf14’s  engagement  with 
chromatin-associated complexes in  vivo, the  mechanism  of  Taf14-directed 
interactions remains poorly defined129,132,216.  
Recently, residues 173-240 of the Taf14 C-terminus have been classified as 
an extra-terminal (ET) domain144 (Figure 18A). Of note, this domain has previously 
been  annotated  as the  Taf14  C-box128. ET  domains  are structuraly  defined  by 
hydrophobic  clusters  containing  3 α-helices,  a  characteristic α2/α3 loop,  and  acidic 
patches that  are  predicted to  act  as  protein-protein interaction  surfaces144,176,256 
(Figure  6A). ET  domains bridge the previously  unrelated  YEATS family  and 
bromodomain  and  extra-terminal (BET) family  proteins144. For  example, the  Taf14 
ET  domain  shows  hydrophobic  cluster  conservation  with  YEATS proteins Sas5 (S. 
cerevisiae), AF9 (H. sapiens), and ENL (H. sapiens), as wel as BET proteins Bdf1 






  8              115        173   240 
YEATS ET Taf14 FL (1-244) 
B 
s.c.Taf14(173-208) VKGSVDLE-KLAFGLTKLNEDD-LVGVVQMVTDNKTPE--!
s.c.Sas5(150-185)  SLRIADLP-WIK-SLALIDEDM-MTDVVQMILNDPAVQ-- !
h.s.AF9(490-525)   KAYLDELV-ELHRRLMTLRERHILQQIVNLIEE--TGH--!
h.s.ENL(493-528)   KAYTDELV-ELHRRLMALRERNVLQQIVNLIEE--TGH--!
s.c.Bdf2(505-540)  HSVDDLKK-SITDKINELSDLE-MNGMIRIIKNSLPADEI!
h.s.BRD4(608-643)  KPMSYEEKRQLSLDINKLPGEK-LGRVVHIIQS-REPS--!
                          :   :  :     :  ::.:: .                  !
s.c.Taf14(209-240) MNVTNNVEEGEFIIDLYSLPEGLLKSLW-DY----VK !
s.c.Sas5(186-216)  RAIENHPRREQFFMFITQLPDDLLMKIQ-AF----LK !
h.s.AF9(526-568)   FHIT----NTTFDFDLCSLDKTTVRKLQ-SY----LE !
h.s.ENL(529-559)   FNVT----NTTFDFDLFSLDETTVRKLQ-SCLEAVAT !
s.c.Bdf2(541-591)  LTSN----EDEIEIDLDILDEATIARIYERYF--EKK !
h.s.BRD4(644-672)  LKNS-N--PDEIEIDFETLKPSTLRELE-RY----VT !
                           : : :  *    :  : !
Figure 18 Taf14 contains an ET domain that is conserved in YEATS and BET 
family  proteins. A.)  Schematic representation  of the S. cerevisiae Taf14  protein. 
The  YEATS  domain (light  blue  hexagon)  spans residues  8-115.   The  ET  domain 
(dark  blue rectangle)  spans residues  173-240144.  B.) Clustal  W  alignment  of 
conserved  ET  domains from  YEATS (blue)  and  BET (green) family  proteins144. 
Hydrophobic  clusters  are  highlighted in  yelow.  Adapted from  Faure  and 
Calebaut144. 
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BRD4 (H. sapiens)144 (Figure 18B). Interestingly, the ET domain of mammalian AF9 
directly binds specific regulators of transcription, including AF4, Dot1L, BCoR, hPC3, 
and Rnf2166,171-177 (Figures  6A,  6B). Likewise, the ET domain of mammalian BRD4 
directly  binds  a  distinct  set  of regulators, including  GLTSCR1,  ATAD5,  NSD3, 
JMJD6,  CHD4, LANA-1 and MLV-IN183,257-259 (Figure  6B). Therefore,  ET  domains 
may generaly function to modulate protein-protein interactions144. 
Importantly, the  ET  domains  of  AF9,  ENL,  and  BRD4  are found in  multiple 
cancer-associated  chromosomal translocations162,163,185,260-262.  MLL-AF9  and MLL-
ENL fusions  aberantly recruit  elongation factors to  HOX genes, resulting in the 
transformation of hematopoietic stem cels and acute leukemia75,160,164,166-170,263. For 
example,  AF9  and ENL  ET  domains bind to AF4, which  activates the P-TEFb 
complex and releases paused RNA  polymerase I (RNAPI) at  coding regions, 
allowing transcription  elongation to  proceed164,166,176. Inappropriate release  of 
paused RNAPI  propagates downstream  pathogenesis via the  overexpression  of 
HOX genes and subsequent hematopoietic stem cel renewal160,169. Disruption of the 
AF9-AF4 interaction  promotes  cel  death in  MLL  cancer  cel lines,  suggesting ET 
domains represent promising pharmacological targets178,180.  
Similarly, the  ET  domain  of  BRD4 interacts  directly  with JMJD6,  which 
activates the P-TEFb complex and releases paused  RNAPI at  coding regions  via 
long-range enhancer interactions181-184. Aberant enhancer-driven P-TEFb activation 
by BRD4-NUT or other BRD4 pathologies is implicated in many diseases including 
midline-carcinoma, acute  myeloid leukemia (AML),  multiple  myeloma, lymphoma, 
sepsis, and  heart  disease185-187,190,191,204.  BRD4 BET bromodomain inhibitors,  such 
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as  JQ1  and I-BET, have  striking  anti-cancer  efects via the  downregulation  of 
oncogenes including MYC, BCL2,  and CDK6186-194.  However, toxicity  and  drug 
resistance remain  a  persistent  problem for  developing  bromodomain-targeted 
therapies264.  To  date, the  ET  domain of  BRD4 remains  pharmacologicaly 
uncharacterized and may provide a novel target for BRD4 pathologies.  
Here,  using  mass  spectrometric,  biochemical,  and  genetic  analyses  we 
further  classify ET  domains as  protein-protein interaction  modules. In the S. 
cerevisiae NuA3  HAT  complex, the  ET  domain  of  Taf14 directly  engages residues 
105-125 of Yng1. Deletion  of the Taf14 ET  domain is  syntheticaly lethal  with  a 
deletion  of the  HAT, GCN5,  suggesting the  ET  domain is required for  NuA3 HAT 
activity. Interestingly, the H.  sapiens ET  domain  proteins  AF9  and  BRD4  also 
engage residues 105-125 of Yng1. Therefore, this S. cerevisiae Yng1 sequence may 
contain a conserved ET domain recognition motif and provide a mechanism to inhibit 
pathological ET domain interactions.  
 
4.2 Methods 
4.2A S. cerevisiae Strains 
Al strains used in Chapter 4 are described in Table 7. 
4.2B S. cerevisiae Plasmids 
Al constructs used in Chapter 4 are described in Table 8. 
4.2C E. coli Plasmids 




S. cerevisiae strains used in Chapter 4 
Strain Genotype Source 









MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
TAF14∆180-244-TAP:HIS3 
A. Raman, S. 
Taverna Lab 
 gcn5∆ 





MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
taf14∆:hph gcn5Δ:kanMX [pmk120] 
S. McDaniel, 




S. cerevisiae plasmids used in Chapter 4 
Name Description Source 
pMK120 CUP1-pr URA3 M. Kuo Lab 
Vector pRS313-3HA B. Strahl Lab 
pTaf14 pRS313-Taf14-3HA 
S. McDaniel, 
B. Strahl Lab 
pTaf14ΔET pRS313-Taf14ΔET-3HA 
S. McDaniel, 





E. coli plasmids used in Chapter 4 
Source: T. Gilbert, S. Taverna Lab 
Name Description Vector 
MBP Alone HIS6X-pfuMBP(aa 60-434)-FLAG pET28 HisMBPFLAG 
Eaf6 FL Eaf6 aa 1-113 pET28 HisMBPFLAG 
Pdp3 FL Pdp3 aa 1-304 pET28 HisMBPFLAG 
Yng1 FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Taf14 ET Taf14 aa 173-240 pET28 HisMBPFLAG 
Sas5 ET Sas5 aa 150-216 pET28 HisMBPFLAG 
Bdf2 ET Bdf2 aa 505-591 pET28 HisMBPFLAG 
AF9 ET AF9 aa 490-568 pET28 HisMBPFLAG 
ENL ET ENL aa 493-559 pET28 HisMBPFLAG 
BRD4 ET BRD4 aa 608-672 pET28 HisMBPFLAG 
N-term(1-140) Yng1 aa 1-140 pET28 HisMBPFLAG 
PHD finger(141-219) Yng1 aa 141-219 pET28 HisMBPFLAG 
Hinge(105-155) Yng1 aa 105-155 pET28 HisMBPFLAG 
Hinge(105-140) Yng1 aa 105-140 pET28 HisMBPFLAG 
Hinge(105-130) Yng1 aa 105-130 pET28 HisMBPFLAG 
Hinge(105-125) Yng1 aa 105-125 pET28 HisMBPFLAG 
Hinge(120-140) Yng1 aa 120-140 pET28 HisMBPFLAG 
Yng1 W180E FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Yng1 P108A FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Yng1 L116W FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Yng1 L117S FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Yng1 K119A FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Yng1 L122W FL Yng1 aa 1-219 pET28 HisMBPFLAG 
Pho23 FL Pho23 aa 1-330 pET28 HisMBPFLAG 
S!tag Alone Thioredoxin-HIS6X-S!tag pET32a 
Taf14 FL Taf14 aa 2-244 pET32a 
Taf14 ΔET Taf14 aa 2-179 pET32a 
Yng1 FL Yng1 aa 2-219 pET32a 
Hinge(105-130) Yng1 aa 105-130 pET32a 
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4.2D Mass  Spectrometric  Protein Identification for  Celular  Pul 
Down Assays 
 
BY471 S. cerevisiae were grown to mid-log phase in YPD, cryogenicaly lysed with a 
mixer mil (Retsch MM301), and stored at −80 °C. Cels (2 g per pul down condition) 
were resuspended in extraction bufer (20 mM HEPES pH 7.9, .1% Tween-20, 2 mM 
MgCl2, 300 mM NaCl, 1 mM PMSF, 2 mM Benzamidine) at a ratio of 10 mL bufer 
per  2  g  yeast.  Cels  were treated  with  ~.002%  DNaseI for  10  min  at room 
temperature.  Cels  were homogenized (ProScientific) and  nutated for  1  hr  at  4 °C. 
Extracts  were  sonicated (Branson)  on the lowest  seting for  12 rounds  of  30  sec  
on/of in  20  mL  aliquots. Clarified  extracts  were  mixed  with  125 µL per  sample of 
Protein  G  Dynabeads (Life  Technologies) that  were pre-coated  with either the 
appropriate  ET  domain (Taf14  ET,  Sas5  ET,  or  Bdf2  ET)  or the HIS6X-pfuMBP(60-
434)-FLAG tag  alone  control.  Extracts  were nutated for 4  hr at  4 °C.  Resin  was 
washed  5 times with extraction  bufer and  1 time  with  bufer  containing 20  mM 
HEPES  pH  7.9, .1%  Tween-20,  2  mM  MgCl2,  and  10  mM  NaCl.  Resin  was 
resuspended in  125 µL per  sample  of  FLAG  peptide (100 µg/mL in  TBS) (F3290, 
Sigma Aldrich) and incubated for 10 min at room temperature with gentle agitation to 
elute  ET  domain/tag-bound  proteins. Supernatant was  colected  and the  FLAG 
peptide elution was repeated 4 times. Eluates were lyophilized, resuspended in 2X 
NuPAGE LDS sample bufer (Life Technologies), boiled for 5 min, and resolved on 
12% NuPAGE  Novex  Bis-Tris gels (Life Technologies).  Gels  were  stained  with 
Simply Blue Safe Stain (Invitrogen) and lanes were excised for tandem MS analysis 
of  peptides with  a  Thermo  LTQ-XL  mass  spectrometer  coupled to  an  Eksigent 
nanoLC 2D system as previously described44. Tandem mass spectra were extracted 
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by  Thermo  ExtractMSn  version  1.0.0.8 and analyzed by Mascot (Matrix  Science, 
London,  UK;  version  2.3.01). Scafold (version  Scafold_4.0.1,  Proteome  Software 
Inc.,  Portland,  OR)  was  used to  validate  MS/MS-based  peptide  and  protein 
identifications. BCMB rotation student Raiha Tahir assisted in yeast preparation and 
Anne  M.  Cieniewicz excised  bands for  MS  analysis.  Al  MS  experiments  and 
analyses were performed by the laboratory of Dr. Alan J. Tacket at the University of 
Arkansas for Medical Sciences. I would like to acknowledge Dr. Alan J. Tacket, Dr. 
Stephanie  D.  Byrum,  and  Lisa  M.  Or for their  many important  contributions to this 
project. 
4.2E Protein Expression 
Constructs  were  made  with  an  N-terminal  HIS6X-pfuMBP(60-434)-FLAG tag (pET28a 
derivative  vector  obtained from the  Greg Bowman  Laboratory,  Johns  Hopkins 
University)  and/or  an  N-terminal  Thioredoxin-HIS6X-S•tag tag (pET32a  vector, 
Milipore).  Proteins  were  exogenously  expressed in  chemicaly  competent  BL21 
(Invitrogen) or Roseta2(DE3) (EMD Milipore) E. coli after overnight induction with 1 
mM IPTG at 18-20 ºC in LB medium. Point mutants were made with the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene) and expressed as described.  
4.2F Protein Purification 
E.  coli cels were resuspended in  purification  bufer (50  mM  Tris  pH  7.5,  500  mM 
NaCl, 40 mM imidazole, 10% glycerol, 5 mM DTT, 1 mM PMSF, 2 mM benzamidine, 
pH 8.0- pET28a constructs) or (50 mM Tris pH 7.5, 500 mM NaCl, 10 mM imidazole, 
10%  glycerol, 5 mM DTT,  1  mM  PMSF,  2  mM  benzamidine,  pH  8.0- pET32a 
constructs) and lysed by sonication (Branson). Clarified lysate was nutated with Ni-
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NTA  agarose resin (Invitrogen) for  at least  1  hr at  4 °C.  Resin  was  washed  with 
purification bufer and protein was eluted with purification bufer containing 300 mM 
imidazole. Protein was frozen in liquid nitrogen and stored at −80 °C. BCMB rotation 
student Raiha Tahir assisted with protein purification. 
4.2G In Vitro Pul Down Assays 
Protein  G Dynabeads (Life Technologies) (50 µL per  sample)  were incubated  with 
FLAG (SIGMA F3165) or S!tag (Abcam 18588) antibody (2 µg per sample) in PBS 
for  1  hr  at room temperature.  Beads  were  washed  with  PBS  and incubated  with 
“bait” proteins (20 µg per sample) in binding bufer (20 mM HEPES pH 7.9, 150 mM 
NaCl, 1 mM PMSF, 2mM Benzamidine, .05% Tween-20, 10% glycerol, .25% BSA) 
for  1  hr  at room temperature. Unbound “bait” was  washed in  binding  bufer  and 
beads  were incubated  with “prey” proteins (20  µg  per  sample) for  1  hr at room 
temperature. Beads were washed 3 times with binding bufer and 1 time with bufer 
containing  4  mM  HEPES  pH  7.9,  10  mM  NaCl, .05%  Tween-20,  and  5%  glycerol. 
Proteins  were  eluted in  boiling  2X  SDS-PAGE loading  bufer. Samples  were 
resolved on 15% or 12% SDS-polyacrylamide gels, transfered to PVDF membrane, 
and  probed  with  antibodies recognizing the  FLAG (SIGMA  F3165,  1/1000) and 
S!tag (Abcam  18588,  1/1000) tags. Immunoblots  were  visualized  using  HRP-
conjugated secondary antibodies (NA931-1ML, 1/10,000 and NA934-1ML, 1/7,500) 
and ECL  solution (GE  Healthcare). Inputs represent  0.25-0.5 µg of  protein.  BCMB 
rotation  student  Raiha  Tahir performed  a  second  biological replicate  of  pul  down 
experiments. I would like to recognize Raiha Tahir for her hard work and dedication 
to this project.    
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4.2H Yeast Strains and Cel Spotting Assays 
S. cerevisiae strains were created using heterologous gene replacement245. For cel 
spoting  assays, 0.5  ODs  of  cels  were  5-fold  serialy  diluted,  spoted  onto the 
appropriate plates, and incubated at 37 °C or 30 °C as indicated for 2 days. Yeast 
strains/plasmids were created by Stephen L. McDaniel in the laboratory of Dr. Brian 
D.  Strahl  at the  University  of  North  Carolina  at Chapel  Hil  and  Ana  Raman.  Cel 
spoting  assays  were  performed  by  Stephen  L.  McDaniel. I  would like to 
acknowledge  Dr.  Brian  D.  Strahl  and  Stephen  L.  McDaniel for their thoughtful 
contributions to this project. 
 
4.3 Results 
4.3A The  ET  Domain  of  Taf14  Directly  Engages  Yng1 in the  NuA3 
HAT Complex  
 
 Taf14 is  a S.  cerevisiae YEATS  domain  protein found in the  NuA3  HAT 
complex and other chromatin-associated complexes105,129. The C-terminus of Taf14 
is required for its interaction  with these  complexes in  vivo129,132,216.  Recently,  C-
terminal residues 173-240 of Taf14 have been classified as an ET domain, which is 
distinguished  by  conserved  hyrdrophobic  clusters that  bridge the  previously 
unrelated YEATS and BET family proteins144 (Figures 18A, 18B).  ET domains are 
predicted to  act  as  protein-protein interaction  surfaces  and  may function  as 
molecular scafolds144,176,256. As the NuA3 efector proteins Yng1 and Pdp3 modulate 
transcription initiation  and  elongation  pathways, respectively,  we  wanted to  probe 
the biological role of the Taf14 ET domain in NuA3-directed transcription. 
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To  determine if the  ET  domain of  Taf14  mediates its interaction  with  NuA3, 
we first tested the ability of ful-length Taf14 to pul down ful-length NuA3 subunits 
Pdp3,  Eaf6,  and  Yng1. Immunoprecipitated  samples  were resolved  by  SDS-PAGE 
and visualized by western bloting. Taf14 directly binds Yng1, but not Pdp3 or Eaf6 
(Figure  19).  We  were  unable to recombinantly  express ful-length  Nto1  and  Sas3, 
and therefore we  could  not  assess  direct interactions  between  Taf14  and these 
subunits. However, previous studies suggest that Taf14 binds Sas3129.  
To establish that the ET domain is required for the interaction between Taf14 
and Yng1, we created a Taf14(2-173) (Δ ET) construct. Taf14 ΔET does not pul down 
Yng1, indicating the ET domain is necessary for binding (Figure 20A). To verify that 
the ET domain is suficient for the interaction between Taf14 and Yng1, we created a 
MBP-HIS6X-FLAG-tagged Taf14(173-240) (ET)  construct.  Taf14  ET  puls  down  Yng1, 
indicating the ET domain is suficient for binding (Figure 20B). Of note, only MBP-
containing  Taf14  ET  constructs  are  stable,  suggesting  yeast  ET  domains  may  be 
intrinsicaly disordered like the human AF9 ET domain176. 
4.3B A  Conserved  Motif  within  Yng1  Binds Yeast  and  Human  ET 
Domains 
 
To further confirm that the ET domain of Taf14 engages Yng1, we tested the 
ability  of ful-length Yng1 to  pul  down Taf14 ET. Yng1 directly  binds  Taf14  ET, 
supporting our previous findings (Figures 20B, 21). To investigate the potential for a 
conserved binding mechanism, we created MBP-HIS6X-FLAG-tagged S. cerevisiae 
ET domain constructs: Sas5(150-216) and Bdf2(505-591), as wel as H. sapiens ET domain 
constructs:  AF9(490-568), ENL(493-559),  and  BRD4(608-672). Again, the  MBP tag  was 





















Figure 19 Taf14 directly interacts with the Yng1 subunit of NuA3. Pul down 
assays were performed with purified Stag alone (-) or ful-length Stag-Taf14 (+) 
coated resin and purified ful-length FLAG-tagged NuA3 subunits: Eaf6, Pdp3, and 
Yng1. Purified proteins (input) and immunoprecipitated samples (IP) were resolved 






















Figure 20 The ET domain of Taf14 is necessary and suficient to interact with 
Yng1. A.) Pul down assays were performed with purified S!tag alone (-) or S!tag-
Taf14 ΔET (+)  coated resin  and  purified ful-length  FLAG-Yng1.  Purified  proteins 
(input) and immunoprecipitated samples (IP) were resolved by SDS-PAGE. Binding 
was monitored by western bloting to FLAG and S!tag. B.) Pul down assays were 
performed  with  purified  FLAG  alone (-)  or  FLAG-Taf14  ET (+)  coated resin  and 
purified ful-length  S!tag-Yng1.  Purified  proteins (input)  and immunoprecipitated 
samples (IP)  were resolved  by  SDS-PAGE.  Binding  was  monitored  by  western 
bloting to S!tag and FLAG. 
 
Figure 21 




s.c. Sas5 ET 
s.c. Bdf2 ET 
h.s. AF9 ET 
FLAG Alone 
h.s. ENL ET 












s.c. Taf14 ET 
Figure 21 Yeast and human ET domains interact with Yng1. Pul down assays 
were performed with purified Stag alone (-) or ful-length Stag-Yng1 (+) coated 
resin and purified FLAG-tagged ET domains: Taf14, Sas5, Bdf2, AF9, ENL, and 
BRD4. Purified proteins (input) and immunoprecipitated samples (IP) were 
resolved by SDS-PAGE. Binding was monitored by western bloting to FLAG and 
Stag. 
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the ET domains of yeast Bdf2 and human AF9, ENL, and BRD4 (Figure  21).  This 
suggests that  a  subset  of  ET  domains recognize  a  conserved  signature  contained 
within the Yng1 protein.  
 We  next  wanted to  define  a recognition  motif  within  Yng1.  We tested the 
ability  of ful-length  Taf14 to  pul  down a  series  of  Yng1 truncation  constructs:  N-
term(1-140), PHD finger(141-219), Hinge(105-155), Hinge(105-140), Hinge(105-130), Hinge(105-125), 
and  Hinge(120-140).  Hinge(105-125) is  suficient to  bind  Taf14,  suggesting  a critical 
recognition  motif  exists  between residues  105-125 of  Yng1 (Figure 22A). 
Importantly, Hinge(105-130) retains an interaction with Taf14 ET, further supporting this 
idea (Figure 22B).  
Interestingly,  Hinge(105-130) also interacts  with  AF9  ET  and  BRD4  ET (Figure 
23A).  We  aligned residues  105-125  of  Yng1  with  known AF9  and  BRD4  binding 
partners176,183. Yng1 contains a motif previously annotated in AF9 interactors, L-X-L-
X-I-X-L, as wel as an upstream L-X-X-P motif176 (Figures 23B,  23C). To determine 
the importance  of these  motifs in  ET  domain recognition, we tested the  ability  of 
Taf14 to  pul  down ful-length Yng1 mutated  at residues P108, L116, L117,  K119, 
L122, and W180. W180E served as a negative control, as this residue is only critical 
for the interaction  between the Yng1 PHD finger  and  H3K4me3. Ful-length Pho23 
was tested  as  an  additional  negative  control,  as  Pho23  contains  a  PHD finger that 
binds  H3K4me3,  but  does  not  contain  either the  L-X-L-X-I-X-L  or  L-X-X-P  motifs. 
L116W, L117S, K119A, and L122W mutations independently abolish or reduce the 














































Figure 22 A smal region of Yng1 is suficient to interact with the Taf14 ET 
domain. A.) Pul down assays were performed with purified Stag alone (-) or ful-
length Stag-Taf14 (+) coated resin and purified FLAG-tagged Yng1 truncations: N-
term(1-140), PHD finger(141-219), Hinge(105-155), Hinge(105-140), Hinge(105-130), 
Hinge(105-125), and Hinge(120-140). Purified proteins (input) and immunoprecipitated 
samples (IP) were resolved by SDS-PAGE. Binding was monitored by western 
bloting to FLAG and Stag. B.) Pul down assays were performed with purified 
FLAG alone (-) or FLAG-Taf14 ET (+) coated resin and purified Stag-Hinge(105-130). 
Purified proteins (input) and immunoprecipitated samples (IP) were resolved by 
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Figure 23 A smal conserved region of Yng1 is suficient to interact with yeast 
and human ET domains. A.) Pul down assays were performed with purified Stag 
alone (-) or Stag-Hinge(105-130) (+) coated resin and purified FLAG-tagged ET 
domains: Taf14, Sas5, Bdf2, AF9, ENL, and BRD4. Purified proteins (input) and 
immunoprecipitated samples (IP) were resolved by SDS-PAGE. Binding was 
monitored by western bloting to FLAG and Stag. * The Stag alone and Stag-
Hinge(105-130) proteins are very close in MW, and therefore these bands appear side 
by side. B/C.) Clustal W alignments of Yng1 with binding partners of AF9 and 
BRD4, respectively169,171-176,183,184. A potential ET domain recognition motif is 
highlighted in red176. 
s.c.Yng1(105-125)   --LEEPGAY--KEPKLLLKINLKKAK---
h.s.BCoR(1181-1207) NHLEDPHYS--ELTNLKVCIELTGLHPKK
h.s.AF4(746-771)    TKLLSPLRDTPPPQSLMVKITLDLLS---
h.s.Dot1L(866-891)  -PISIPLSTV-QPNKLPVSIPLASVVLP-
                      :  *        .* : * * 
 
Figure 24 


































Figure 24 Mutation of a conserved motif within Yng1 disrupts Taf14 binding. 
Pul down assays were performed with purified Stag alone (-) or ful-length Stag-
Taf14 (+) coated resin and purified ful-length FLAG-tagged Yng1 constructs: WT, 
W180E, P108A, L116W, L117S, K119A, and L122W. Ful-length FLAG-Pho23 was 
also tested. Purified proteins (input) and immunoprecipitated samples (IP) were 
resolved by SDS-PAGE. Binding was monitored by western bloting to FLAG and 
Stag. 
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region  of  Yng1  surounding  and including the  L-X-L-X-I-X-L  motif is  critical for 
binding  Taf14. Conversely,  as P108A  has  no  afect  on  Taf14  binding, the L-X-X-P 
motif may generaly be dispensable for ET domain interactions (Figure 24).   
Since the  ET  domains  of  AF9  and  BRD4  propagate  aberant  protein-protein 
interactions in  many  diseases including midline-carcinoma, leukemia, sepsis, and 
heart disease, a shared recognition signature (such as L-X-L-X-I-X-L) may provide a 
novel mechanism to block downstream pathogenesis164,185,204. We hypothesize that 
with  optimization  a  biologic  could  be  constructed to  specificaly  and  potently  block 
ET domain interactions.  
4.3C NuA3 Requires the ET domain of Taf14 for Functional Activity 
 
To further understand the biological role of ET domains, we investigated the 
importance  of the  Taf14  ET  domain in  vivo.  We find that taf14∆ET has  growth 
defects that phenocopy taf14∆, indicating the ET domain is critical for Taf14 function 
(Figure 25A). It  has  previously  been  determined that SAS3 and YNG1 display 
synthetic lethality  with the  HAT, GCN5, as NuA3  and Gcn5-associated  complexes 
both  acetylate  H3K14 to promote transcription110,242,244,252. To  determine if Taf14 
regulates NuA3  HAT  activity, we performed  a GCN5 plasmid shufle assay in the 
gcn5∆taf14∆ background. Interestingly, both gcn5∆taf14∆ and gcn5∆taf14∆  + 
pTaf14∆ET cels show synthetic lethality, indicating TAF14 geneticaly interacts with 
GCN5 (Figure 25B). These data suggest that the ET domain of Taf14 is required for 
NuA3-directed H3K14ac HAT activity. We speculate that through an interaction with 







Figure 25 The ET domain of Taf14 is required for NuA3 H3K14ac HAT activity. 
A.) 0.5 ODs of the indicated S. cerevisiae strains were 5-fold serialy diluted onto 
SC -Ura -His plates and grown at 30 oC (left) or 37 oC (right) for two days. B.) 0.5 
ODs of the indicated S. cerevisiae strains were 5-fold serialy diluted onto SC -Ura 
-His (left) or SC -Ura -His + 5-FOA (right) plates and grown at 30 oC for two days. 
These experiments were performed by Stephen L. McDaniel in the laboratory of Dr. 






























SC -Ura -His: Day 2 5-FOA: Day 2 
SC -Ura -His: Day 2 SC -Ura -His: Day 2 
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4.3D Yeast ET Domains Facilitate Protein-Protein Interactions 
 As  ET  domains are  predicted to  act  as  protein-protein interaction  modules 
and the Taf14 ET domain is required for NuA3 HAT activity, we performed a screen 
to search for novel yeast ET domain interactors144. Purified Taf14 ET, Sas5 ET, and 
Bdf2 ET were used as “baits” and incubated with wild type S. cerevisiae lysate. The 
MBP-HIS6X-FLAG tag  alone  was  used  as  a  control for  non-specific  binding. 
Immunoprecipitated samples were resolved by SDS-PAGE and subjected to tandem 
MS  analysis.  Relative  spectral  counts  were  calculated for  each  ET  domain  and 
compared to the tag  alone control.  Enriched  ET  domain  binding  partners  were 
categorized by gene ontology (GO) analysis. Recombinant ET domains from Taf14, 
Sas5,  and  Bdf2 interact  with  many  diverse  protein families, including  members  of 
biosynthetic,  metabolic, translation, complex  subunit  organization, transcription 
initiation, and gene expression pathways (Figures 26A, 26B, 26C). 
As  NuA3 regulates transcriptional  activation,  we focused  on interactions 
relating to transcription initiation  and  gene  expression  pathways55,66. Taf14  ET 
interacts  with known Taf14-associated  complexes: TFID,  TFIF, Ino80,  and 
SWI/SNF (Figure  27).  Taf14  ET  also interacts  with  many transcriptional  activators 
including  RNAPI/II,  CDK, the  pre-initiation  complex,  elongation factors,  and  ATP-
dependent  RNA  helicases (Figure  27).  Sas5  ET interacts  with the transcriptional 
activators Ino80 and RNAPI/I/II, as wel as the transcriptional repressors CCR-NOT 
and Iswi1 (Figure 28). Bdf2 ET interacts with Ino80, RNAPI/I/II, Swr1, SAGA/SILK, 
elongation factors,  ATP-dependent  RNA  helicases,  and linker  histone  H1 (Figure 




Taf14 ET-Associated Biological Processes Number of Hits P-Value 
Metabolic process 181 1.974e-21 
Biosynthetic process 121 3.845e-20 
Translation 37 3.728e-08 
Protein folding 18 2.599e-06 
DNA-templated transcriptional preinitiation complex assembly 11 5.667e-06 
Macromolecular complex assembly 36 2.612e-04 
Gene expression 72 8.765e-04 
Macromolecular complex subunit organization 46 3.135e-03 
A 
Figure  26  Gene  Ontology  analysis  of  proteins  co-purifying  with  yeast  ET 
domains. A/B/C.)  Endogenous  proteins  co-purifying  with recombinant S. 
cerevisiae Taf14 ET, Sas5 ET, and Bdf2 ET “baits” were identified by tandem MS 
analysis.  Spectral  count  enrichment  was  calculated relative to the tag  alone 
control.  Enriched  proteins (2-fold  or  greater)  were  categorized  by  gene  ontology 
analysis. Biological processes with P < .01 are listed. 
B 
Sas5 ET-Associated Biological Processes Number of Hits P-Value 
Biosynthetic process 66 9.293e-09 
Metabolic process 101 2.210e-08 
Translation 22 8.243e-05 
Regulation of DNA-templated transcription initiation 6 1.749e-04 
Proteasome assembly 6 2.762e-03 
Macromolecular complex assembly 23 3.150e-03 
Ubiquitin-dependent protein catabolic process 13 5.871e-03 
Protein complex subunit organization 20 7.071e-03 
Bdf2 ET-Associated Biological Processes Number of Hits P-Value 
Metabolic process 239 4.740e-19 
Biosynthetic process 140 7.166e-13 
Translation 49 7.250e-10 
Protein folding 24 4.634e-08 
Postranscriptional regulation of gene expression 20 2.306e-03 





Name Spectral Count Enrichment Taf14 ET-Associated Complex 
Taf2 32.00 TFID 
Taf8 12.46 TFID 
Taf4 8.73 TFID 
Taf12 7.87 TFID 
Taf5 7.67 TFID 
Taf6 7.52 TFID 
Ino80 6.34 Ino80 
T2fb 6.16 TFIF 
Taf10 5.31 TFID 
Rpb11 4.36 RNAPI 
Rpc1 4.00 RNAPII 
Lsm3 3.88 Lsm8p 
Taf9 3.78 TFID 
Sub2 3.70 TREX 
Rvb1 3.61 Ino80/Swr1/R2TP 
Cdk1 3.55 CDK 
Snf2 3.20 SWI/SNF 
Snf5 2.87 SWI/SNF 
Sas5 2.67 Sas2/4/5 
Pab1 2.65 PABP 
Utp10 2.63 SSU processome 
Swi3 2.54 SWI/SNF 
Smd2 2.54 snRNP 
Tbp 2.38 Preinitiation complex 
Ies4 2.25 Ino80 
Dbp2 2.18 ATP-dependent RNA helicase 
Spt6 2.17 Elongation factor 
Ded1 2.16 ATP-dependent RNA helicase 
Rpb1 2.14 RNAPI 
Rpac2 2.04 RNAPI/II 
Figure  27  The  ET  domain  of  Taf14  mediates  protein-protein interactions. 
Endogenous  proteins  co-purifying  with recombinant S.  cerevisiae  Taf14  ET “bait” 
were identified by tandem MS analysis. Spectral count enrichment was calculated 
relative to the tag  alone  control.  Enriched  proteins (2-fold  or  greater) involved in 
DNA replication, transcription, and RNA processing are listed. 
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Name Spectral Count Enrichment Sas5 ET-Associated Complex 
Not3 6.71 CCR4-NOT 
Rpc2 5.85 RNAPII 
Rvb1 5.28 Ino80/Swr1/R2TP 
Iswi1 4.97 Iswi1 
Rpa34 4.92 RNAPI 
Rpc1 4.04 RNAPII 
Utp10 3.33 SSU processome 
Rpb11 3.32 RNAPI 
Rpa12 3.02 RNAPI 
Rfc2 2.88 Replication Factor C 
Pds5 2.52 Cohesion Maintenance Factor 
Rpb1 2.31 RNAPI 
Rpa2 2.15 RNAPI 
Ino80 2.09 Ino80 
Figure 28 
Figure  28  The  ET  domain  of  Sas5  mediates  protein-protein interactions. 
Endogenous proteins  co-purifying  with recombinant S. cerevisiae  Sas5  ET “bait” 
were identified by tandem MS analysis. Spectral count enrichment was calculated 
relative to the tag  alone  control.  Enriched  proteins (2-fold  or  greater) involved in 
DNA replication, transcription, and RNA processing are listed. 
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Name Spectral Count Enrichment Bdf2 ET-Associated Complex 
Mbf1 8.29 Multiprotein Bridging Factor 
Pab1 5.05 PABP 
Smt3 4.92 SUMO family 
Nhp6a 4.87 HMG protein family 
Spt6 3.92 Elongation factor 
Rvb1 3.81 Ino80/Swr1/R2TP 
Rad23 3.37 NEF2 
Sub2 3.25 ATP-dependent RNA helicase 
Rpc1 3.07 RNAPII 
Swr1 3.01 Swr1 
Sas5 3.00 Sas2/4/5 
Dbp2 2.79 ATP-dependent RNA helicase 
Rpac2 2.70 RNAPI/II 
PCNA 2.69 PCNA 
Dbp5 4.46 ATP-dependent RNA helicase 
Spt5 2.41 DSIF 
Utp10 2.39 SSU processome 
Rpb11 2.36 RNAPI 
Rvb2 2.36 Ino80/Swr1/R2TP 
Top2 2.21 Topoisomerase I 
Prp43 2.18 RNA helicase 
Def1 2.18 RNAPI degradation factor 
H1 2.16 Linker histone 
Ded1 2.11 ATP-dependent RNA helicase 
Chd1 2.06 SAGA/SILK 
Rpa12 2.05 RNAPI 
Figure 29 
Figure  29  The  ET  domain  of  Bdf2  mediates  protein-protein interactions. 
Endogenous  proteins  co-purifying  with recombinant S. cerevisiae  Bdf2  ET “bait” 
were identified by tandem MS analysis. Spectral count enrichment was calculated 
relative to the tag  alone  control.  Enriched  proteins (2-fold  or  greater) involved in 
DNA replication, transcription, and RNA processing are listed. 
! 91!




Here  we further  characterize  ET  domains  as  protein-protein interaction 
modules. We determine that the ET domain of S. cerevisiae Taf14 engages multiple 
chromatin-associated  complexes including  TFID,  TFIF, Ino80,  SWI/SNF,  and 
NuA3. Within the NuA3 complex,  Taf14  ET  binds residues  105-125 of Yng1. 
Disruption of this interaction results in growth defects and synthetic lethality with the 
HAT, GCN5, suggesting the ET  domain  of Taf14 facilitates  NuA3  H3K14ac  HAT 
activity. We  also find that the ET  domains  of S.  cerevisiae Sas5 and  Bdf2 interact 
with  multiple transcriptional  activators. Therefore,  ET  domains  may generaly 
contribute to transcriptional regulation by bridging chromatin-associated complexes.  
Interestingly, the ET  domains  of H. sapiens AF9  and  BRD4  also  engage 
residues 105-125 of Yng1, which contain a conserved recognition motif: L-X-L-X-I-X-
L176. We  hypothesize that with  optimization,  a  biologic  could  be  constructed to 
specificaly  and potently inhibit  ET  domain interactions.  For  example,  disruption  of 
the  AF9-AF4 interaction with a peptide mimetic promotes  cel death in  MLL  cancer 
cel lines178,180. Such inhibitors may  provide  a  novel treatment mechanism to  block 
pathogenesis in ET-domain associated diseases164,178,180,185,204. 
Recently, “reader”  domain targeted therapies  have  demonstrated  clinical 
benefits.  For  example, the  BET  bromodomain inhibitors  JQ1 and I-BET  selectively 
target BRD4 and show promise for treating multiple forms of leukemia, inflammation, 
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and  heart  disease in  mouse  models190,191,195,204,205. JQ1 and I-BET derivatives  are 
curently in  phase I  clinical trials for midline  carcinoma,  hematological  cancer,  and 
solid tumors187,265. However, such “reader” targeted therapies have serious toxicities. 
Recent  studies from  Genentech  and  Astra  Zeneca  determined that JQ1 treatment 
results in  significant  weight loss, immunosuppression,  and  gastrointestinal  atrophy, 
which makes JQ1 treatment intolerable for long-time use264. Therefore, alternatively 
targeting the  BRD4  ET  domain may improve tolerance  by  specificaly  blocking 
aberant protein-protein interactions. 
Many  questions remain  about the function  of  ET  domains. For  example,  do 
ET  domains  act  solely  as  scafolding  modules  or  do they  alostericaly regulate the 
activity of their associated protein? Within NuA3, Taf14 ET does not bind the Yng1 
PHD finger and conversely, mutation of the Yng1 PHD finger does not disrupt Taf14 
binding. Therefore, the ET domain of Taf14 likely does not alostericaly regulate the 
Yng1-H3K4me3 interaction. However, we determined that the ET domain of Taf14 is 
necessary for NuA3-directed HAT activity. Based on our MS data, we speculate that 
the ET  domain  of Taf14 functions  as  a  molecular  scafold,  which  bridges  NuA3 to 
TFID,  TFIF, Ino80,  SWI/SNF,  and other  chromatin-associated  complexes129. 
Interestingly, Yng1 shares conserved hydrophobic residues with multiple subunits of 
Taf14-containing complexes including RSC30 of RSC, Snf5 and Snf11 of SWI/SNF, 
and  Tfg2  of  TFIF.  Taf14-containing  complexes  may  physicaly interact by Taf14 
dimerization  or by exchanging conserved subunits, to facilitate transcriptional 
activation. Although intriguing, these models require future testing. 
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Finaly, a human homolog of Taf14, AF9, binds H3K9ac through a conserved 
YEATS  domain139,265. Therefore,  Taf14  may  also  bind acetylated  histones.  We 
speculate that  via its  direct interaction  with  H3K4me3-binding  Yng1,  Taf14  may 



















Chapter 5: General Discussion 
 
 
Although each cel in the human body contains the same DNA, diferent cel 
types  express  unique  gene  signatures that  can be inherited through  epigenetic 
mechanisms1. Epigenetic  mechanisms  are  propagated in  part through post-
translational  modifications (PTMs) of  histone  proteins2,3,5,6. As the  disruption  of 
epigenetic mechanisms leads to aberant gene expression and epigenetic diseases 
including cancer,  heart  disease, inflammation,  and  neurological  disease, 
understanding the function  of histone  PTMs at  a  molecular level is  critical for 
therapeutic development7,8,195-198. 
Histone PTMs occupy discrete genomic positions, such as promoter regions 
versus open reading frames (ORFs), and are  associated  with  distinct celular 
processes,  such  as gene  expression versus gene  silencing17,19,31,33,53,210-212. For 
example,  histone  H3 is  often  both trimethylated  on lysine  4 (H3K4me3)  and 
acetylated  on lysine  14 (H3K14ac)  at the  5’-ends  of transcriptionaly  active 
genes23,31-33,52,53,133. Alternatively, H3K36me3 is found throughout the ORFs of active 
genes32,33,53,209. The “histone  code”  hypothesis  predicts that  combinatorial  histone 
PTMs act  as  binding  sites for  efector proteins, which can transduce  downstream 
activity through  chromatin-associated  complexes13,17,19. As the conserved S. 
cerevisiae NuA3 histone acetyltransferase (HAT) complex modulates its localization 
and activity by  engaging (“reading”)  and  adding (“writing”) these  diferentialy 
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positioned histone PTMs, we use NuA3 as a model to study the “histone code” in the 
context of transcriptional activation55,66,104-108,110. 
Here  we classify  NuA3 into two functionaly  distinct forms:  NuA3a  and 
NuA3b66. NuA3a specificaly binds H3K4me3 through the plant homeodomain (PHD) 
finger  of the  Yng1  subunit55,107.  NuA3a subsequently acetylates  H3K14, leading to 
transcription initiation  at  a  subset  of  genes55,105,106.  NuA3b contains the  unique 
member,  Pdp3,  a proline-tryptophan-tryptophan-proline (PWWP)  domain  protein66. 
NuA3b binds H3K36me3 through the  PWWP  domain  of  Pdp3 to facilitate 
transcription elongation66. The target of NuA3b HAT activity is not yet known, but is 
likely independent of H3K1466. 
These findings contribute to the “histone code” hypothesis in two ways. First, 
we ascribe a new function to H3K36me3 in yeast. In addition to repressing intergenic 
transcription through the recruitment  of histone  deacetylase (HDAC)  complexes, 
H3K36me3 also positively regulates transcription elongation through the recruitment 
of HAT  complexes63-66,223,224,228. The  ability  of  a  single  modification to promote 
opposing  celular processes, suggests that additional  binding mechanisms  are 
required to properly target these complexes. Accordingly, NuA3a/b contains multiple 
efector proteins, including Yng1 and Taf14. Yng1 and Taf14 may bind H3K4me2/3 
and  histone  acetylation, respectively, to fine tune  NuA3b localization at specific 
ORFs55,107,139.  Such  combinatorial  paterns  could direct  diferential  HAT  and  HDAC 
recruitment  at  H3K36me3-enriched  chromatin. Second,  we  demonstrate that 
NuA3a/b changes HAT specificity based on subunit composition. This phenomenon 
is  conserved in  humans,  as the related HBO1 HAT  complex can  switch  between 
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histone H4 and H3 acetylation depending on the association of JADE versus BRPF 
subunits254. Therefore,  subunit  exchange  may  generaly increase the  plasticity  of 
chromatin-associated complexes. 
Finaly, we characterize extra-terminal (ET) domains as mediators of protein-
protein interactions. Specificaly, the ET domain of Taf14 engages residues 105-125 
of Yng1 and this interaction is critical for NuA3-directed H3K14ac HAT activity. We 
speculate that the Taf14 ET domain functions as a molecular scafold, which bridges 
NuA3 to  TFID,  TFIF, Ino80,  SWI/SNF,  and  other  chromatin-associated 
complexes129. Interestingly, the H. sapiens ET domain proteins AF9 and BRD4 also 
engage residues  105-125 of Yng1.  Therefore, this  Yng1  sequence  may  contain  a 
conserved  ET  domain recognition  motif  and  provide  a  novel  mechanism to  block 
pathogenesis in  ET-domain related diseases164,178,180,185,204. We  hypothesize that 
targeting the “reader” domains and protein-protein interaction surfaces of chromatin-
associated  complexes,  as  opposed to the enzymatic  subunits,  may increase the 













A.1 The YEATS Domain of Taf14 Binds Histones In Vitro 
TAF14 is not an essential gene, but deletion of al three S. cerevisiae YEATS 
domain-containing genes (TAF14, SAS5, YAF9) is lethal128. Therefore,  YEATS 
domains  serve a required (yet undetermined) function in  yeast. Since YEATS 
domains can bind histones in vitro, we tested the ability of ful-length Taf14 and the 
Taf14 YEATS  domain to  pul down  endogenous total core  histones from T. 
thermophila138,175. Immunoprecipitated  samples  were resolved  by  SDS-PAGE and 
visualized by  western  bloting to  histone  H3. The YEATS  domain of  Taf14 is 
suficient to bind histones in vitro (Figure 30A). In this manner, Taf14 may contribute 
to a combinatorial histone “code” to target NuA3-directed H3K14 acetylation (Figure 
30B). 
 
A.2 Disruption  of the  Spt16-Sas3 Interaction Enhances 6-
Azauracil Sensitivity Under Stress Conditions 
 
The  histone  chaperone,  FACT, facilitates  both transcription initiation  and 
elongation  by  exchanging  histone  H2A/H2B  dimers266. Sas3 is  known to directly 
interact  with  FACT through  Spt1644,105. To  connect Sas3 to the transcription 
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Figure 30 The YEATS domain of Taf14 is suficient to interact with histones in 
vitro and  may  contribute to  NuA3 targeting. A.)  Pul  down  assays  were 
performed with purified ful-length S!tag-Taf14 (+) coated resin or FLAG-YEATS (+) 
coated resin  and  endogenous total  core  histones from T. thermophila. 
Immunoprecipitated  samples (IP)  were resolved  by  SDS-PAGE.  Binding  was 
monitored  by  western  bloting to  histone  H3.  Histones  were  obtained from  Dr. 
Romeo Papazyan. B.) Hypothetical model of the NuA3 HAT complex. The YEATS 
domain  of  Taf14  may  engage  histones139. In this  manner,  Yng1  and  Taf14  may 
“read” a combinatorial “histone code” to target NuA3-directed H3K14ac at specific 






















transcription elongation inhibitor that shows distinct growth phenotypes with mutants 
of elongation machinery. We find that a mutant of Spt16 (spt16-11), which blocks the 
Spt16-Sas3 interaction, displays 6-AU sensitivity under stress  conditions (Figure 
31). Similarly,  deletion  of the Sas3 C-terminus (sas3Δ657),  which also  blocks the 
Spt16-Sas3 interaction, displays 6-AU sensitivity (Figure 31). These results suggest 
that under  stress  conditions, FACT recruitment  via  Sas3 facilitates transcription 
elongation. Yeast  strains  were designed  and created  by the  Alan J. Tacket 
laboratory at the University of Arkansas for Medical Sciences. 
 
A.3 Disruption  of the  Yng1  PHD  Finger  and the  Pdp3 
PWWP  Domain  Synergisticaly  Enhances  6-Azauracil 
Resistance Under Stress Conditions 
 
The  PHD finger  of  Yng1  and the  PWWP  domain  of  Pdp3  are  known to 
facilitate transcription initiation  and  elongation, respectively,  by recruiting the  NuA3 
HAT complex to  chromatin55,66,106. S.  cerevisiae strains  containing  a  deletion  of 
SET2, or  downstream H3K36me3 efectors, show  a  6-AU resistance 
phenotype218,224. Using  genetic  spoting  assays,  we find that combined mutation  of 
the  Yng1  PHD finger (yng1ΔPHD) and the Pdp3  PWWP  domain (pdp3W21A) 
synergisticaly enhances 6-AU resistance under  stress  conditions (Figure  32). 
Therefore, the Yng1 PHD finger may contribute to  NuA3 targeting at  ORFs  during 


















Figure  31  Disruption  of the  Spt16-Sas3 interaction  enhances  6-azauracil 
sensitivity under stress conditions.  Three-fold serial dilutions of the indicated 
S. cerevisiae strains  were  spoted  onto  SC  media in the  absence (left)  or 
presence (right) of 100 ug/mL 6-azauracil (6-AU).  The plates were incubated at 
































Figure  32  Disruption  of the  Yng1  PHD finger  and the  Pdp3  PWWP  domain 
synergisticaly  enhances  6-azauracil resistance  under  stress  conditions. 
Three-fold serial dilutions of the indicated S. cerevisiae strains were spoted onto 
SC  media in the  absence (left)  or  presence (right)  of  150 ug/mL  6-azauracil (6-
AU). The plates were incubated at 37 °C for three days.    
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A.4 Yng1 Dimerizes In Vitro 
A human  homolog  of  Yng1, ING4, contains  a  dimerization  domain267. We 
therefore tested the  ability  of ful-length Yng1 to  dimerize in  vitro. 
Immunoprecipitated  samples  were resolved  by  SDS-PAGE and  visualized  by 
western  bloting. Yng1 dimerizes with itself,  but  not with the related  PHD finger 
protein Pho23 (Figure 33). This suggests that like the NURF chromatin-remodeling 












Figure  33  Yng1 dimerizes in  vitro. Pul  down  assays  were  performed  with 
purified S!tag alone (-) or ful-length S!tag-Yng1 (+) coated resin and purified ful-
length  FLAG-tagged  Yng1  and  Pho23.  Purified  proteins (input)  and 
immunoprecipitated  samples (IP)  were resolved  by  SDS-PAGE.  Binding  was 
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